Tarascon Plastic Surgery Pocketbook
Tarascon Plastic Surgery Pocketbook
& Reconstructive
Surgery Pocketbook
From the publishers of the Tarascon Pocket Pharmacopoeia®
Jones & Bartlett Learning books and products are available through most bookstores and online booksellers.
To contact Jones & Bartlett Learning directly, call 800-832-0034, fax 978-443-8000, or visit our website,
[Link].
Substantial discounts on bulk quantities of Jones & Bartlett Learning publications are available to
corporations, professional associations, and other qualified organizations. For details and specific
discount information, contact the special sales department at Jones & Bartlett Learning via the above
contact information or send an email to specialsales@[Link].
Copyright © 2014 by Jones & Bartlett Learning, LLC, an Ascend Learning Company
All rights reserved. No part of the material protected by this copyright may be reproduced or utilized in
any form, electronic or mechanical, including photocopying, recording, or by any information storage and
retrieval system, without written permission from the copyright owner.
Tarascon Plastic & Reconstructive Surgery Pocketbook is an independent publication and has not been
authorized, sponsored, or otherwise approved by the owners of the trademarks or service marks referenced
in this product.
The authors, editor, and publisher have made every effort to provide accurate information. However, they
are not responsible for errors, omissions, or for any outcomes related to the use of the contents of this
book and take no responsibility for the use of the products and procedures described. Treatments and side
effects described in this book may not be applicable to all people; likewise, some people may require a dose
or experience a side effect that is not described herein. Drugs and medical devices are discussed that may
have limited availability controlled by the Food and Drug Administration (FDA) for use only in a research
study or clinical trial. Research, clinical practice, and government regulations often change the accepted
standard in this field. When consideration is being given to use of any drug in the clinical setting, the health
care provider or reader is responsible for determining FDA status of the drug, reading the package insert,
and reviewing prescribing information for the most up-to-date recommendations on dose, precautions, and
contraindications, and determining the appropriate usage for the product. This is especially important in the
case of drugs that are new or seldom used.
Production Credits
Executive Publisher: Christopher Davis
Senior Acquisitions Editor: Nancy Anastasi Duffy
Editorial Assistant: Marisa LaFleur
Production Assistant: Alex Schab
Marketing Manager: Rebecca Leitch
Manufacturing and Inventory Control Supervisor: Amy Bacus
ISBN: 978-1-4496-3636-4
6048
Printed in the United States of America
16 15 14 13 12 10 9 8 7 6 5 4 3 2 1
To Dr. Louis Carter, whose service and example convinced me to pursue this
remarkable field.
EDITORIAL BOARD
Affiliations are given for information purposes only, and no affiliation sponsor-
ship is claimed. James A. Chambers, MD, MPH, authored this book in his private
capacity. The views expressed in this book do not necessarily represent the
views of either the United States Air Force or the United States Government.
ACRONYMS
AbDM abductor digiti minimi
AIN anterior interosseous nerve
APL abductor pollicis longus
AVN avascular necrosis
BR brachioradialis
CMC carpometacarpal joint
CRPP closed reduction (and) percutaneous pinning
DIP distal interphalangeal
DIPJ distal interphalangeal joint
DISI dorsal intercalated segment instability
DRUJ distal radioulnar joint
EAC external auditory canal
ECRB extensor carpi radialis brevis
ECRL extensor carpi radialis longus
ECU extensor carpi ulnaris
EDC extensor digitorum communis
EDM extensor digitorum minimus
EDQ extensor digiti quinti
EIP extensor indicis proprius
EPB extensor pollicics brevis
EPL extensor pollicis longus
FCR flexor carpi radialis
FCU flexor carpi ulnaris
FDP flexor digitorum profundus
FDS flexor digitorum superficialis
FPB flexor pollicis brevis
FPL flexor pollicis longus
IF index finger
IO interosseous
IP interphalangeal
IPJ interphalangeal joint
LABCN lateral antebrachial cutaneous nerve
LF long (or little) finger (author recommends using MF for
middle finger and SF for small finger for disambiguation)
LT lunotriquetral
MACS minimal access cranial suspension
MCPJ metacarpophalangeal joint
MF middle finger
MMF maxilomandibular fixation
MP metacarpophalangeal
MPJ metacarpophalangeal joint
N nasion
NOE nasoorbital fracture
b. Method of transfer
i. Advancement: flap carried to new position by sliding technique,
w/o any rotation or lateral movement
– V-Y, Y-V
– Single pedicle
– Bipedicle
– Transposition (rectangular)
– Z-plasty
• Variation of transposition flap; two triangular flaps are
reversed and rotated 90°
• Useful for lengthening scars or changing direction of scar
• Central limb is along scar, and the two other limbs must
be of equal length to central limb
• End result is with central limb perpendicular to original
orientation
• Angle of Z-plasty → theoretical gain in length of central
limb
○ 30° → 25%
○ 45° → 50%
○ 60° → 75% (most commonly performed)
○ 75° → 100%
○ 90° → 120%
• Optimal angle is 60° degrees (balances tension and gain
in length)
• One large Z-plasty releases more than multiple small
Z-plasties
x y
b B
a a b
B A
x2
y2
FIGURE 1.4 Z-Plasty.
Creation of 60° angles results in 75% increase in x-x’ to y-y’
– W-plasty
• Useful for scar lengthening or scar excision
• Cross mark lines are drawn across and perpendicular to scar
– Rhomboid flap
A C
A B
(continues)
(continues)
TABLE 1.3 Classifi cation (Information from Mathes SJ, Nahai F, Plast Reconstr
Surg. 1981 Feb 67(2):177–87)
Skin
Flap Paddle POC* Arc of Rotation Size (cm) Vessel (dominant/minor) Nerve (motor, sensory)
36364_CH01_001-[Link] 11
Gastrocnemius Possible I Inf thigh, knee, upper third tibia 20 × 8 Medial/lateral sural m: Tibial branches
(medial/ s: saphenous(m), sural(l)
lateral)
Tensor fascia Possible I Abdominal wall, groin, perineum, 5 × 15 Asc branch lateral circumflex m: superior gluteal
lata trochanter, ischium, sacrum femoral s: T12+ lat fem cutaneus
Soleus No II Middle (and distal) one third tibia 8 × 28 d: Popliteal, posterior tibial, m: posttibial + medial
peroneal, m: posterior tibial popliteal
Gracilis Possible II Groin, perineum, vagina, anus, 6 × 24 d: Asc branch med circumflex m: ant branch obturator
ischium femoral, m: superficial femoral s: ant fem cutaneus
Rectus femoris Possible II Anterior trunk, midabdomen, groin, 20 × 8 d:des branch lat circumflex femoral m: femoral
perineum m: lat circumflex fem, superficial s: ant fem cutaneous
femoral
Rectus Possible III Anterior thorax, groin, perineum, 25 × 6 d: sup + inf epigastric m+s: intercostal 7–12
Wound Healing, Coverage, and Locoregional Anesthesia
(continues)
1/3/13 7:19 PM
TABLE 1.4 (continued )
12
Skin
Flap Paddle POC* Arc of Rotation Size (cm) Vessel (dominant/minor) Nerve (motor, sensory)
36364_CH01_001-[Link] 12
Gluteus maximus Possible III Sacrum, ischium + 24 × 24 d: sup + inf gluteal m: inf gluteal (L5–S2)
perineum, rectum, vagina m: branches profunda femoris, s: S 1–3, L 1–3
(gluteal thigh flap) lat circumflex femoral
Serratus anterior Possible III Chest wall, shoulder, axilla, back, 15 × 20 d: lateral thoracic, branches m: long thoracic (C5–7)
intrathoracic cavity thoracodorsal s: intercostal (T2–4)
Extensor hallucis No IV Lower third tibia 3 × 24 Branches ant tibial m: ant tibial
longus
Tibialis anterior Possible IV Upper + middle third tibia 4 × 25 Branches anterior tibial m + s: ant tibial
Wound Healing, Coverage, and Locoregional Anesthesia
Latissimus dorsi Possible V Neck, skull, thorax, sternum, lower 25 × 35 d: thoracodorsal m: thoracodoral (C6–8)
fsce, upper abdomen m: branches postintercostal, s: lat cutaneous
lumbar
1/3/13 7:19 PM
Wound Healing, Coverage, and Locoregional Anesthesia 13
9. Optimizing fl ap survival
a. Physical factors
i. Keep edges moist, minimize desiccation
ii. Avoid (vasoconstrictive) hypothermia
iii. Preconditioning flaps (intentionally induced periods of isch-
emia, followed by reperfusion, may periodically clamp pedicled
flap before division)
iv. Hyperbaric oxygen
b. Pharmacologic
i. Pro-survival
– Anticoagulants
• Heparin
• Leeches (Hirudo medicinalis) → Hirudin, for venous
congestion
○ Caveat: Aeromonas hydrophila, prophylactic antibiot-
ics (fluroquinolone or TMP-SMX)
• Aspirin
– Thrombolytics
• Urokinase, streptokinase for venous thrombosis
– Vasodilator
• Calcium (Ca)-channel blockers
• Topical nitroglycerin paste (advise patient may cause
headaches)
• Amrinone
• PGI2 and analog iloprost
– Free radical scavengers (none often used clinically)
• Allopurinol → inhibits xanthine oxidase → decreases
free radicals
• Superoxide dismutase
• Deferoxamine
– Oxygen: consider supplemental oxygen for borderline flaps
to increase survival
– Controversial:
• Dextran: inhibits platelet aggregation, but risk of ana-
phylaxis, pulmonary edema
10. Perfusion issues
a. Venous insufficiency
i. Suggested as primary cause of necrosis in pedicled flap tissue
(Krizek TJ, Hoopes JE, Symposium on Basic Science in Plastic
Surgery, Mosby, St. Louis, 1976, Vol 15, Ch 28, pp. 241–59;
Angel MF, et al., Plast Reconstr Surg, 1990;85(5):789–93)
b. Arterial insufficiency
i. Suggested as primary cause of skin flap failure (Kerrigan CL,
Plast Reconstr Surg, 1983;72(6):766–77)
ii. Combination of ischemia, inflammation, sympathectomy; may
be the cause for flap failure
A. ANATOMY
1. Osteology
a. Vault
i. Frontal bone
ii. Temporal bone
iii. Parietal bone
iv. Occipital bone
b. Face
i. Zygoma
– Articulates w/ greater wing of sphenoid, maxilla, frontal,
and temporal bones (last joints via slender zygomatic
arch) forming two faces, the lateral (malar) and the medial
(orbital). Arch is formed by junction of zygoma and zygo-
matic process of temporal bone
– Attachment for masseter (major deforming force w/ frac-
ture), temporalis, zygomaticus, portion of orbicularis oculi
• Ethmoid
• Sphenoid
• Maxilla
• Palatine
c. Sinuses
i. Frontal: absent at birth, begin to form by 2 yrs, radiographically
visible by 6 yrs, full size by 15 yrs
– Pyramid-shaped w/ apex superior and inferior floor that
forms medial aspect of orbital roof
– Posterior table forms portion of anterior cranial fossa, rela-
tively thin, 0.1 to 4.8 mm
– Anterior table forms portion of forehead, brow, glabella, av.
4 mm thick, up to 12 mm
– 10% of patients with unilateral sinus, 5% minimal sinus,
4% no sinus
– Nasofrontal recess (NFR) provides drainage for each frontal
sinus (FS), with ostial dimensions of 3 × 4 mm located at
posterior inferior aspect of sinus floor
ii. Maxillary
iii. Ethmoidal
iv. Sphenoid
d. Mandible
i. Coronoid process: temporalis muscle inserts here
ii. Condylar process: articulates with glenoid fossa
iii. Angle: masseter (lateral) and medial pterygoid (medial) muscles
attach here
iv. Alveolar process: supports teeth
v. Cartilaginous disk: at temporomandibular joint (TMJ), serves
as point of attachment of transverse head of lateral pterygoid
muscles
e. Fissures and foramina
i. Skull base
– Foramen ovale
• Contains V3
– Stylomastoid foramen
• Contains CN VII
– Jugular foramen
• Contains CN IX, X, and XI
– Foramen spinosum
• Contains middle meningeal artery
ii. Intraorbital
– Optic canal
• Passes through lesser wing of sphenoid
• Contains optic nerve (CN II) and ophthalmic artery and vein
– Superior orbital fissure
• Bounded by the greater and lesser wings of the sphenoid
and ethmoid
• Contains CN III, IV, VI, and sympathetics
– Inferior orbital fissure
• Bounded by maxilla, zygoma, greater wing of the sphenoid
• Contains CN V2
iii. Facial
– Supratrochlear
– Infraorbital
– Maxillofacial
– Mental
– Anterior ethmoid foramen
• Contains anterior ethmoid vessels
2. Spaces
a. Buccal space
i. Above mylohyoid muscle
ii. Infection may result from spread from maxillary molars
b. Retropharyngeal space
i. Posterior to pharynx and extending down to level of T2
ii. Pathway of spread of dental infection into the mediastinum
c. Submandibular space
i. Inferolateral to mylohyoid, superior to hyoid bone
ii. Contains submandibular gland, facial a., facial n vein, LN’s,
and inferior loop of CN XII
iii. Communicates anteriorly with submental space and posteriorly
with pharyngeal space
iv. Infection may result from spread from second and third man-
dibular molars (roots are beneath mylohyoid)
d. Submental
i. Medial to anterior bellies of the digastric muscles
ii. Contains submental lymph nodes
e. Sublingual
i. Superomedial to mylohyoid muscle
ii. Infection may result from spread from mandibular teeth ante-
rior to second molars
3. Vasculature
a. Common carotid
i. Branches off of aortic arch (left = direct branch, right = from
innominate artery)
ii. Bifurcates at the level of C4 into internal and external carotid
arteries
iii. External carotid branches (inferior → superior)
– Superior thyroid
– Ascending pharyngeal (branches posteriorly)
– Lingual
– Occipital (branches posteriorly)
– Facial
– Posterior auricular (branches posteriorly)
– Bifurcates terminally into the internal maxillary artery and
the superficial temporal artery
• Internal maxillary artery
○ Passes through pterygomaxillary fissure (at right angle
to inferior orbital fissure)
○ Common source of bleeding in facial fx
• Descending palatine is a branch along posterior aspect of
lateral nasal wall (at risk during LeFort 1 osteotomy)
V: trigeminal
V1 – ophthalmic division V1 – superior orbital V1 – sensation to scalp,
V2 – maxillary division fissure upper eyelid, cornea, nose,
V3 – mandibular division V2 – foramen rotundum and meninges
V3 – foramen ovale V2 – sensation to lower lid
and cheek, nares, upper
lip, and palate
V3 – general sensation
anterior 2 ⁄3 tongue
– muscles of mastication
iii. Walls
– Superior (roof): arched, thin, but rarely fractured due to pro-
tection of frontal sinus, frontal bone, and supraorbital rim;
exception is children. See orbital fx section below that follows
– Inferior (floor): medial aspect is maxillary bone
– Medial: composed of palatine bone, lacrimal bone, and
lamina papyracea of the ethmoid
– Lateral: composed of zygoma and greater wing of sphenoid
iv. Eyelid: upper lid has four layers; lower lid similar, but lacks
levator muscle
– Skin and subcutaneous fat: loose, can accommodate sig-
nificant fluid/edema
– Musculature (orbicularis oculi)
• Divisions
○ Orbital (outer rim; provides tight eyelid closure)
• Originates from medial orbital rim and medial canthal
tendon
○ Palpebral (exceedingly thin; provides reflex/uncon-
scious closure, and aids lower lid contact w/ globe)
• Preseptal: between orbital and pretarsal; superficial to
orbital septum
○ Originates from medial canthal tendon and lacrimal
diaphragm, inserts in lateral canthal tendon
• Pretarsal: innermost; superficial to tarsal plate
○ From medial canthal tendon and contribute to lateral
canthal tendon
• Vasculature: from external facial a. branches that arise
from branches of ophthalmic a
– Tarsus
• Upper tarsal plate ~10 mm in vertical height (~29 mm
long and 1 mm thick)
• Lower tarsal plate ~4 mm in vertical height (~29 mm
long and 1 mm thick)
– Conjunctiva: palpebral and bulbar components
– Orbital septum: extends from arcus marginalis (bony rim
of orbit) toward tarsus. In upper lid, inserts into levator
aponeurosis 2–5 mm above tarsus. In lower lid, it attaches
to tarsus and fuses with periorbita at bony rim. Medially,
attaches to lower end of anterior lacrimal crest, passing
from lower to upper lid under orbicularis oculi. Laterally,
passes just anterior to lateral canthal tendon
– Medial canthus: fibrous support of the lid; extends from medial
tarsus and has anterior and posterior limbs that surround the
lacrimal sac. Main insertion is posterior lacrimal crest
– Lateral canthus: fibrous support of the lid; extends from the
lateral tarsal margin and inserts onto Whitnall’s tubercle
~1.5 mm posterior to lateral orbital rim
b. Physiology
i. Lacrimal system
– Tears produced by three sets of glands
• Goblet cells (mucinous product)
• Accessory lacrimal glands (aqueous product)
• Meibomian, Zeiss, Moll (oily product)
– Dry eyes
• Etiology: computer use, antihistamines, antihyperten-
sives, antidepressants, diabetes, lupus, thyroid disease,
rheumatoid arthritis, Sjögren’s syndrome
• Evaluate with Schirmer’s test
○ Schirmer’s I: filter paper strip inserted into lower con-
junctival sac and allowed to sit for 5 minutes. (a normal
test has >10 mm of wetting of the filter paper)
○ Schirmer’s II: similar to Schirmer’s I, but topical anes-
thetic is used, eliminating reflex tearing
– Epiphora: excessive tearing; investigate lacrimal system for
obstruction
– Chemosis: edema of the conjunctiva; nonspecific sign of eye
inflammation
ii. Scleral show: seen in 5% of population
iii. Eye opening (lid retraction)
– Upper lid (90% of eye opening)
• Levator palpebrae superioris: innervated by CN III (oculo-
motor nerve)
• Müller’s muscle: innervated by sympathetic fibers, loss of
which (Horner’s syndrome) results in 2–3 mm of ptosis
– Lower lid
• Capsulopalpebral head of inferior rectus muscle
iv. Pupillary function
– Miosis (small pupil) = parasympathetic; mydriasis (dilated
pupil) = sympathetic
– Direct papillary response: pupil should constrict in response
to direct (ipsilateral) light (intact ipsilateral afferent optic
nerve = CN II; efferent parasympathetics = CN III)
– Consensual papillary response: pupil should constrict in
response to contralateral light (intact contralateral = CN II;
ipsilateral = CN III)
– Accommodation: pupils should constrict when focused on
approaching object (intact = CN II, III)
– Afferent papillary defect (Marcus-Gunn pupil): decreased or
absent pupillary constriction of both eyes when light shined
in affected eye
– Horner’s syndrome: miosis, lid ptosis, anhydrosis (due to
sympathetic chain interruption in upper thorax)
9. Nose
a. Support
i. Proximal third: nasal bones, bony septum
ii. Middle third: upper lateral cartilages, cartilaginous septum
iii. Distal third: cartilaginous septum, lower lateral cartilages
(medial, middle, and lateral crura)
b. Soft tissue envelope
c. Vasculature
i. Angular arteries (from facial aa): supply each side of nose
ii. Lateral nasal and septal arteries (from facial artery): provide
branches to ala and septum
iii. Dorsal nasal branch (of ophthalmic aa): supply dorsum, nasal
sidewalls
iv. Infraorbital branch (of internal maxillary aa): supply dorsum,
nasal sidewalls similar to to dorsal nasal branch of ophthalmic
artery
d. Innervation
i. Sensory (from trigeminal nerve = CN V)
– Ophthalmic division (V1)
• Nasociliary n.: direct sensation to nose
• Infratrochlear n.: indirect sensation to nose
• External branch of anterior ethmoidal n.
– Maxillary division (V2)
• Provides branches via infraorbital nerve to nasal side-
walls and caudal septum
ii. Motor: facial nerve (CN VII) innervates procerus, depressor
septi nasi, and nasalis
10. Ear
a. External structure: helix (w/ root and tail), antihelix (w/ superior and
inferior crura), tragus, antitragus, intertragal, concha, scapha, cymba,
lobule. Normal dimensions: 6–6.5 cm high, 3.5 cm wide, projects
17–21 mm from temporal scalp
b. Vasculature
i. Superficial temporal artery (from ext carotid): supplies lateral
auricle
ii. Posterior auricular artery (from ext carotid): supplies posterior
auricle, lobule, and retroauricular skin
iii. Occipital artery (from ext carotid): supplies posterior auricle, lob-
ule, and retroauricular skin similar to posterior auricular artery
c. Innervation
i. Great auricular nerve (C2, C3): sensory to lower half of lateral
ear and posterior auricle
ii. Auriculotemporal nerve (V3): sensory to superolateral surface
of ear and anterior and superior external auditory canal
iii. Lesser occipital nerve: sensory to superior cranial surface of ear
iv. Arnold’s nerve (auricular branch of vagus): sensory to concha
and posterior external auditory canal
11. Scalp
a. Layers: Skin, Connective tissue (subcutaneous tissue), Aponeurosis
(frontalis muscle, galea), Loose areolar layer, Periosteum
b. Most mobility in skin/subcutaneous tissue over parietal scalp; little
mobility on vertex or occiput
12. Oral cavity and teeth
a. 32 adult teeth (16 in each dental arch): 12 molars, 8 bicuspids,
4 canines, 4 lateral incisors, 4 central incisors
i. Numbered from right to left in maxilla (1–16) and left to right in
the mandible (17–32)
b. 20 primary teeth (10 in each dental arch): 4 molars, 2 canines,
2 lateral incisors, 2 central incisors
i. Lettered right to left in the maxilla (A–J) and left to right in the
mandible (K–T)
ii. There are NO bicuspid teeth in primary dentition
c. Dental terminology
i. Mesial: side of the tooth that is toward the center of the mouth
ii. Distal: side of tooth furthest from the center of the mouth
(toward the back of the mouth)
iii. Lingual: toward the tongue
iv. Buccal: toward the cheek
d. Alveolar ridge: bony ridge of both mandible and maxilla that contain
the tooth sockets (alveoli)
e. Palatal anatomy
i. Primary palate: derived from the premaxilla, portion of the bony
palate anterior to incisive foramen (just behind the central
incisors)
ii. Secondary palate: formed by the palatine process of the maxilla
and the palatine bone, posterior to the incisive foramen
13. Lips
a. Topography
i. Vermillion: red portion of lip, divided into dry (keratinized) and
wet or moist (nonkeratinized)
ii. Vermillion border (mucocutaneous line, white roll): transition
from skin to mucosa of lip
iii. Cupid’s bow: upper central vermillion border at base of philtral
columns (others define as entire upper lip)
iv. Intercommissural distance: in a normal adult at rest, 6 cm
b. Aesthetic units
i. Lateral wings: between philtral columns and nasolabial folds
ii. Philtrum: between philtral columns
iii. Lower lip: between vermillion and labiomental fold
iv. Vermillion: between vermillion border and dry-wet line
c. Musculature
i. Orbicularis oris: divided into superficial and deep portions
ii. Superficial orbicularis: controls oral sphincter function, which
pouts/purses lips (acts as a coronal sphincter)
iii. Deep orbicularis: keeps lips coated to the teeth (acts as an
axial sphincter)
d. Innervation
i. Motor
– Facial n. (CN VII)
• Buccal branch
• Marginal mandibular branch
ii. Sensory
– Upper lip: infraorbital nerve (V2)
– Lower lip: mental nerve (V3)
e. Vasculature: facial artery gives rise to superior and inferior labial
arteries deep to orbicularis oris, 1 mm posterior to white roll, and
1 mm deep to lip mucosa
f. Lymphatics: upper and lower lateral lips drain to submandibular
nodes; central lower lip drains to submental nodes
B. SURGICAL APPROACHES
1. Periorbital (exposes infraorbital rim and orbit – medial and lateral
walls as well as floor)
a. Transcutaneous (subciliary, subtarsal, and infraorbital rim incisions)
i. Exposes infraorbital rim, orbital floor, medial and lateral orbital
walls, and superior maxilla
ii. Keep incision in thin eyelid skin (not malar) and avoid crossing
skin tension lines laterally if possible
iii. Mark skin incision 2 mm/7mm inferior to lashes (subciliary/
subtarsal)
iv. Subciliary incision has high incidence of lower lid malposition
when used for trauma exposure compared to subtarsal approach
b. Transconjunctival
i. Exposes orbital floor, will need transcaruncular extension or
lateral canthotomy for visualization of medial or lateral walls,
limited exposure of infraorbital rim
ii. Incise ~5 mm from depth of conjunctival fornix, can dissect
anterior or posterior to orbital septum for exposure of floor or to
access lower lid fat compartments
c. Supraorbital eyebrow
i. Exposes lateral wall and zygomaticofrontal (ZF) suture
ii. Incision placed in lateral tail of brow extending along lateral
orbital rim
iii. Scar is not in a natural crease and has a tendency to cause
brow alopecia
d. Upper eyelid
i. Exposes upper medial orbital wall, superior orbital rim, orbital
roof, and ZF suture
ii. Incision placed in natural upper eyelid crease and can be
extended laterally in an existing skin crease for ZF suture
exposure
iii. Keep >1 cm between upper and lower lid incision extensions
laterally to avoid prolonged postoperative lid edema
2. Coronal (exposes frontal bones, upper face, zygomatic arch)
a. Zigzag incision beginning 1 cm superior and posterior to helical
root, extending posteriorly first
b. Incise behind hairline (in balding men, consider from preauricular
to preauricular or further back [mid-portion may curve anteriorly];
if possible, maintain ~4 cm behind hairline). A hemicoronal incision
may also be used but offers limited exposure
i. A preauricular extension can be used to access the TMJ or zygo-
matic arch
c. Keep hair out of field by twisting small bundles with hemostats and
placing rubber bands loaded on hemostat
d. Hemostasis may be aided by: injecting epinephrine solution into
subgaleal plane; running locking sutures of 2–0 monofilament along
edge; cautery knife; Raney clips
e. Mark midline, then lateral. Incise to areolar tissue below galea,
but above pericranium. Limit initial incisions between temporalis
muscles laterally to avoid excess bleeding
3. Transoral
a. Maxilla
i. Upper gingivobuccal sulcus incision
– Incision made ~5–7 mm on mucosa of upper lip, running
from first molar to contralateral first molar
– Leave a small cuff of muscle on mucosa to aid in closure
– Can expose maxilla, anterior zygoma, and access pterygo-
maxillary junction
b. Mandible
i. Lower gingivobuccal sulcus incisions
– Can tailor incisions to needed exposure; be mindful of the
mental nerve (foramen at level of second bicuspid)
– Similar principles as with upper incision
– Re-suspend mentalis with sutures or external taping to pre-
vent postoperative chin ptosis
4. Transfacial mandible
a. Submandibular (Risdon)
i. Incision placed ~2 cm below inferior border of mandible
ii. Careful dissection through platysma (marginal mandibular
branch of CN 7 just deep to it)
iii. May require division of facial artery and vein for exposure
f. Musculocutaneous flaps
i. Pectoralis major flap: based on thoracoacromial artery for head
and neck reconstruction; can provide muscle or skin coverage
for anterior and lateral defects of the lower 1⁄3 of the face
ii. Latissimus dorsi flap: based on thoracodorsal artery; can provide
pedicled coverage for lower facial defects or be used as a free
flap to cover large scalp defects (in conjunction with skin grafts)
iii. Trapezius flap: based on transverse cervical artery for head and neck
reconstruction; can provide coverage of the lower third of the face
g. Free tissue transfer: becoming the workhorse of head and neck
reconstruction
i. Anterolateral thigh (ALT) flap
ii. Radial forearm flap
iii. Rectus abdominis flap
iv. Latissimus dorsi flap
2. Nose
a. Nine aesthetic subunits (Burget GC, Menick FJ, Plast Reconstr Surg.
1985 Aug;76(2):239–47)
i. Dorsum
ii. Tip
iii. Columella
iv. Sidewalls (2)
v. Alae (2)
vi. Soft triangle (2)
b. Nasal lobule composed of: tip, alae, nostril sills, and columellae
c. General rules:
i. Place incisions along borders of adjacent subunits when possible
ii. If defect >50% of subunit, excise remainder and reconstruct
entire subunit
iii. When available, use undamaged contralateral subunit as
model for reconstruction
iv. Divide large defects into multiple subunits, and address each
with a separate graft or flap for best aesthetic results
– Defects should be assessed for missing components*:
• Skin
• Structural support
• Mucosal lining
*Each component must be replaced
– Nonanatomic placement of cartilage grafts for support will
bolster large reconstruction from contractile forces during
the healing process and prevent secondary deformities
– Nasal dorsum and sidewalls
• Banner flap: good for defects <1.2 cm
• Bilobed flap: for lateral defects <1.5 cm; flaps remain
medially based to prevent using cheek skin
• Dorsal nasal flap: for lower dorsum, supratip lobule (at
least 1 cm from alar rim); can close up to 2-cm defects
– Ala
• Nasolabial flap: can reconstruct entire alar subunit; will
need nonanatomic cartilage grafts for support
– Tip
• Small tip defects (<1 cm) can be closed with full-
thickness skin graft (FTSG), although cosmetic defect
will be noticeable
• Paramedian forehead flap most useful for tip and colu-
mella reconstruction
• Must stage flap and provide nonanatomic cartilaginous
support to prevent unsightly scar contracture
– Mucosa
• Turnover flap: incising margin of healed wound and turn-
ing skin in to recreate mucosal lining; good for small
defects
• Mucosal “buckethandle” flap: bipedicled flap of intra-
nasal mucosa advanced into alar/caudal defect; donor
defect resurfaced with an FTSG
• Septal mucosal flap: septal mucosa from contralateral
nasal airway elevated and passed through septal incision
to line ipsilateral airway
• Ipsilateral septal mucosa can be elevated based on septal
branch of superior labial artery and rolled on itself for lining
– Support
• Strut: bone or cartilage graft anchored to radix (K-wire or
screw fixation) to give dorsal support; can be combined
with columellar strut for total support of nose; referred to
as a cantilever graft if columellar extension not used
• Septal flap: septum (L-shaped) is hinged superiorly to
augment nasal dorsum
• Anatomic cartilage grafts: cartilage (septum, concha,
rib) used to replace nasal cartilages
• Nonanatomic cartilage grafts: used to lend support to
existing cartilages to resist scar contracture
○ Alar batten graft: placed cephalad to alar rim; support
external nasal valve but do not correct alar notching
○ Alar contour graft: placed along alar rim; provides har-
monious alar contour
○ Lateral crural strut: placed deep to lower lateral carti-
lage and extends to piriform aperture; helps reposition
lower lateral cartilages and resist alar collapse
○ Spreader graft: placed between dorsal septum and
upper lateral and lower lateral cartilage; prevents/
treats internal nasal valve collapse; can treat pinched
tip deformities
3. Oral cavity
a. General: tend to be complex defects with poor functional outcomes.
Goals are to allow for passageway for food and air, and to provide
tongue bulk for swallowing and speech function
b. Floor of mouth/tongue: goal of reconstruction is to provide bulk to
obliterate dead space when speaking or swallowing. Options include
pedicled pectoralis, free rectus, or free ALT flaps
c. Soft palate: thin flaps can provide closure of defect but are non-
functional (free radial forearm flap, pedicled temporalis flap); con-
sider palatal prosthetics as an option
d. Hypopharynx and esophagus: small defects with adequate
mucosal lining can be closed primarily. Circumferential or near-
circumferential defects merit reconstruction. Flaps include:
i. Pedicled, tubed pectoralis
ii. Free tubed radial forearm
iii. Free tubed ALT (this is becoming the workhorse for cervical
esophageal/laryngeal reconstruction)
iv. Free jejunum
v. Long segment; more distal reconstructions will require a gas-
tric pull-up or colonic interposition
4. Mandible
a. General: planning on the size of the defect is critical in planning a
reconstruction, with respect to both bone and soft tissue
b. Nonvascularized bone grafts: adequate for <6 cm defects with
healthy soft tissue envelope. Iliac crest is preferred donor site. May
not have enough bone stock for later dental implant placement. No
ability to provide missing soft tissue elements
c. Sterilized autogenous bone
d. Alloplasts: titanium reconstruction bar can span a bony defect, but
will fracture with time (~6–9 months); good for patients as part of
a staged reconstruction or in those with limited life expectancy
e. Vascularized bone: necessary when bony defect >6 cm or for central
mandibular defects (involving symphysis and both parasymphyseal
regions)
f. Composite mandibular defects
i. Free fibula is donor site of choice
ii. Radial forearm flap provides excellent thin soft tissue coverage;
bone stock generally not amenable to later implant placement
iii. Free scapula flap provides excellent soft tissue bulk; bone stock
generally not amenable to later implant placement
g. TMJ reconstruction: difficult to restore complex functional proper-
ties of a native TMJ via any method
i. Numerous methods of TMJ reconstruction; need to recreate
cartilaginous surface of glenoid fossa for adequate rotation
and translation of joint complex
– Vascularized rib: used primarily in younger patients (9–10 yr)
with severe mandibular hypoplasia (hemifacial microsomia);
has a tendency to become hyperplasic after transplantation
D. TRAUMA
1. Facial fractures
a. General: approximately 11% of trauma patients sustain maxillofa-
cial injuries requiring intervention (Girotto JA, et al., Plast Reconstr
Surg, 2001;108(2):312–27); evaluate for brain, spine, ophthalmo-
logic injuries
b. Physical exam
i. Inspect for contusions, lacerations, edema, hematoma (i.e.,
septal), asymmetries, and visible deformities
ii. Palpate the horizontal and vertical buttresses of the face for
step-offs
iii. Check for midface stability
iv. Gross visual exam
v. Assess occlusion
c. Radiography
i. CT maxillofacial region
– Axial, coronal, +/– sagittal views (thin cuts 1.0–1.5 mm)
– Assess integrity of horizontal and vertical buttresses (these
are the thickest portions of the bone where plate fixation
must be placed during repair)
– Categorize facial fracture patterns (i.e., LeFort level, zygo-
maticomaxillary complex, orbital, mandible, pan facial, etc.)
ii. Frontal sinus: recommend Rodriguez ED, el al., Plast Reconstr
Surg, 2008;122(6):1850–66
– General
• Frontal bone requires greatest force to fracture relative to
any facial bone
• FS fractures are associated with other significant inju-
ries about 75% of the time, including nasoorbitoethmoid
(NOE) fx
• Isolated anterior table fx 33%, combined fx 67%, isolated
posterior table fx rare
• Posterior table fx can be associated with cerebrospi-
nal fluid (CSF) leak (therefore, consider neurosurgery
involvement for evaluation if severe fx or leak)
– Presentation
• Suggestive sx include: upper facial edema/ecchymoses,
diplopia, forehead hematoma/abrasions, epistaxis, supra-
trochlear/supraorbital paresthesias
• CSF rhinorrhea (ask about “salty” post nasal drip): check
“halo” test, fluid glucose, a/o beta2-transferrin
○ Review CT scan for involvement of anterior and poste-
rior table fractures and severity, proximity to nasofron-
tal ducts, pneumocephalus
– Treatment
• Options (depending on findings) may include observation,
ORIF, sinus obliteration, or sinus cranialization.
• Surgical exposure via coronal flap, or, for isolated anterior
table fx, may consider going through frontal lacerations
○ Anterior table fx
• ORIF: if significant contour irregularity exists, use mini-
plast for anterior table fixation
• Alternately, consider cyanoacrylates for thin bone fragments
• Consider possibility of nasofrontal duct injury
○ Jones test
■ Jones test I: stain corneal tear film with 2% fluorescein
dye, then check for stain under inferior turbinate with
cotton swab 5 min later. If cotton swap stains, then
patency of nasolacrimal duct assured; negative test
means possible duct block
■ Jones test II: if above test results in no dye found
from inferior turbinate, irrigate lower canaliculus
with saline. If dye can be recovered from inferior
turbinate, indicates partial or functional block
• Frontal sinus obliteration for anterior table fracture
involving the nasofrontal ducts
○ Remove all mucosal lining to prevent mucocele
○ Obliterate of duct and sinus with cancellous bone grafts
and/or vascularized soft tissue (i.e., pericranial flap)
○ Avoid free fat and muscle grafts as they risk necrosis
and resorption
• Isolated fractures around the duct may be appropriately
treated with stenting or dilation of duct
○ Posterior table fx
• Cranialization: appropriate if anterior and posterior table
fractures are significantly displaced, CSF leak, posterior
table comminution
○ Perform in conjunction with neurosurgeon
○ Facilitates inspection (and repair) of dura and naso-
frontal duct
○ Use coronal approach for craniotomy, then remove
posterior table and sinus mucosa
v. Timing
– When periorbital edema subsides (no urgency for repair,
unless there is true entrapment)
– Urgent repair indicated (24–48 h) for true trapdoor fracture
with entrapment
• May present with pain with attempted eye movement,
bradycardia (oculocardiac reflex), or nausea and vomit-
ing (oculogastric reflex)
– Ocular/globe injury is contraindication for early surgery
(i.e., hyphema aggravation may cause acute closed-angle
glaucoma)
– Retrobulbar hematoma: emergent orbit decompression with
a lateral canthotomy at bedside
vi. Surgical approach
– Access to the orbit is provided via a lower eyelid incision
– Transconjunctival or subtarsal incision
– Transconjunctival incision can be performed with a presep-
tal or retroseptal dissection
– Can combine with lateral canthotomy to increase exposure
(canthus needs to be repaired during closure)
– Combine transconjunctival with a retrocaruncular extension
for improved access to the medial wall if necessary
– Subciliary incision has highest risk for ectropion
vii. Materials for orbital floor and/or medial wall fractures
– Bone graft
• Alloplastic implants
○ Titanium mesh
○ MEDPOR (high-density porous polyethylene)
• Polyethylene
○ Resorbable implants (best for pediatric patients and
small defects)
○ Silastic
d. Blow-in fractures
i. Rare, can occur with intraorbital displacement of the lateral
wall, may cause impingement of lateral rectus
ii. Treated with simple reduction of the lateral wall segment
e. Orbital roof fractures
i. Rare, may present with proptosis and diplopia, most small
fractures can be left untreated
ii. Repair if large defect and persistent diplopia
iii. Uncomplicated fractures can be reduced via upper blepharo-
plasty incision and roof reduction
iv. May need frontal craniotomy and skull base reconstruction with
split calvarial bone graft for complex injuries
v. Large unrepaired defects can result in persistent exophthalmos
and pulsatile proptosis
c. Presentation
i. Midface and/or periorbital edema
ii. Epistaxis
iii. Malocclusion (typically anterior open bite)
iv. Midface instability may be present (if severe impaction of max-
illa, the midface may clinically feel stable)
d. Fracture patterns
i. Dentoalveolar: involvement of teeth and supporting structures
ii. Palate fracture
iii. LeFort fractures: need disruption of pterygoid plates and ante-
rior buttresses to destabilize the maxilla
– LeFort I: transverse fracture across maxilla
– LeFort II: pyramidal fracture to include nasal bones as
disjunction occurs through medial orbit and nasofrontal
suture
– LeFort III: complete craniofacial disjunction as fractures
across zygomatic frontal suture, through orbits and zygo-
matic arch
e. Treatment
i. Goals of repair are to restore pretraumatic occlusion
ii. Exposure dependent on fracture type: incisions can include
upper sulcus, or lower, upper, or coronal eyelid
iii. Dentoalveolar fractures are stabilized with arch bar across
maxillary arch
iv. Palate fractures can be stabilized with horizontal miniplate
across the fracture line along the lower maxilla. Combine with
arch bars and elastics to maintain appropriate occlusion
v. ORIF for LeFort fractures
vi. Maxillary disimpaction and placement in MMF necessary prior
to plate fixation of anterior buttresses
vii. Primary bone graft to buttresses if bony gaps exist due to
comminution
viii. Consider postoperative elastics for several weeks to maintain
occlusion
f. Complications of maxillary fractures and/or repair: malocclusion
and maxillary malposition
7. Panfacial fractures
a. Fractures of the upper face, midface, and mandible
b. Multiple surgical approaches will be required (coronal incision for
access to upper skeleton and zygomatic arches)
c. ORIF necessary moving from stable regions to unstable
i. Can perform top-down or bottom-up approach (start with fixa-
tion from the most stable peripheral bone)
d. Goals of reconstruction are to restore occlusion, and to reestablish
normal facial width and height and projection
• Champy technique
• Monocortical angle plate
• Inferior border plate +/– monocortical plate (easier via
external Risdon incision)
– Mandibular body fracture
• Access via intraoral lower sulcus incision (identify
and preserve the mental nerve, which exists near the
premolars)
• Optimal treatment with a two-plate technique (tension
band and stabilization plate)
• Consider stab incision and trocar assist to help with
placement of inferior border plate
– Parasymphyseal fractures
• Access via lower sulcus incision
• Optimal treatment with a two-plate technique (tension
band and stabilization plate)
– Symphyseal fractures
• Access via lower sulcus incision
• Optimal treatment with a two-plate technique (tension
band and stabilization plate)
• May also consider stabilization with two lag screws
e. Pediatric mandible fractures
i. Condyle is growth center for (primarily) vertical growth
ii. Generally remodel, but fracture can cause growth disturbance,
ankylosis, and hypoplasia
iii. If no malocclusion: soft diet and early range of motion
iv. If malocclusion: consider functional MMF for 1–2 weeks
v. Difficult to place children in arch bars given that primary teeth
are short and there are often missing teeth in mixed dentition
vi. Tooth buds in mandible limit options for internal fixation
vii. Use only monocortical screws
viii. Consider resorbable plates and screws
ix. Fracture healing is faster in children, therefore, can treat with
MMF for shorter period of time (2–4 weeks versus 4–6 weeks in
adults)
f. Edentulous patients
i. Lack of dentition and poor bone stock
ii. Decreased healing capacity
iii. Favor external approaches and less periosteal stripping (place
plates in the preperiosteal plane for improved reduction and
maintenance of microcirculation to the bone)
iv. Use large plates (i.e., reconstruction plates); miniplates and
small plates contraindicated
v. May need to use primary bone grafts in the severely atrophic
mandible
E. TUMORS
1. Epidemiology
a. 3–5% of all new cancer diagnoses in the United States each year
b. Oral cavity: one location for head and neck cancer
i. 59% overall 5-year survival
– Early lesions >85% survival
– Late stage <25% survival
– 66% of oral cancer patients present with advanced disease
ii. 92% of oral cancer patients are over 40 (avg. 63) (Horner MJ, et
al., SEER Cancer Statistics Review, 1975–2006, National Cancer
Institute, Bethesda, MD, based on November 2008 SEER data
submission, posted to the SEER web site, 2009)
2. Oropharyngeal tumors
a. Etiology: smoking (most important; cessation for 10 years decr. risk
50%), EtOH (synergistic with tobacco, risk if >50 g/day), HPV, betel
quid, UV/sun overexposure
i. 25% of all oral cancer victims have no identifiable risk factors
b. Location
i. Lesions of concern
– Leukoplakia: white patch that cannot be rubbed off; located
on floor of mouth >> lateral tongue, lower lip > other
• DDx: hyperkeratosis +/– dysplasia, carcinoma in
situ, invasive carcinoma, lichen planus, Candida, etc.
Majority without dysplasia (Bornstein MM, et al., Schweiz
Monatsschr Zahnmed, 2004;114(7):680–6)
– Erythroplakia: red plaque, often velvet in appearance.
Located on floor of mouth > soft palate/anterior tonsillar
pillar/retromolar trigone > lateral tongue. >90% severe
dysplasia, CIS, or invasive carcinoma
c. Diagnosis
i. Head and neck exam: sensitivity ~60%, specificity 98%
– Sites: skin of head and neck
• Neck: lymph nodes, salivary glands, carotid, thyroid,
other masses
• Oral cavity, oropharynx: visualize all mucosa, palpate the
tongue, lips, cheek, and floor of mouth
• Nose, nasopharynx
• Larynx: can use mirror or flexible nasopharyngoscopy
ii. Tissue: scraping/cytology, FNA, biopsy (incisional/excisional)
iii. Imaging: CT, MRI, PET
T2: <2 , but >4 cm N2a: 1 ipsilateral node M1: Distant metastasis
>3, but <6 cm
vii. Diagnosis
– Clinical presentation: palpable mass, facial nerve impair-
ment, asymmetry of mouth, eye irritation, parapharyngeal
fullness, trismus, skin ulceration
– Rule of 80s for parotid masses
• 80% of tumors will be benign
• 80% will be in the superficial lobe
• 80% will be pleomorphic adenoma
– Key concepts or questions
• In mass lesions of PS area, is the mass intra- or extraparotid?
• What is the mass relationship to facial nerve?
• Designate mass as superficial, deep, or in the same plane
as intraparotid facial nerve
• Intraparotid CN7 estimated along line between stylomas-
toid foramen and lateral margin of retromandibular vein
• If malignancy in PS known or suspected, is there evidence
of perineural CN VII tumor?
○ Check fat in “bell” of stylomastoid foramen
○ If fat is obliterated, T1 C+ MR indicated
• Is the lesion single or multiple? Unilateral or bilateral?
○ Multiple bilateral lesions suggest unique differential
diagnosis
○ Consider Sjögren’s syndrome, benign lymphoepithelial
lesions associated with HIV, Warthin’s tumor, NHL,
acinic cell, or systemic metastases
○ If CN VII functions normally preoperatively, it generally
should be preserved
viii. Surgery
– Superficial parotidectomy: removal of the lateral portion
of the gland with preservation of the facial nerve; typical
operation for a parotid mass located superficial to the facial
nerve
– Superficial parotidectomy with partial deep lobe resection:
removal of the superficial gland and a portion of the gland
deep to the facial nerve
– Superficial parotidectomy with total deep lobe excision:
removal of the entire gland for tumors originating in the
deep lobe or for malignant neoplasms with suspected
metastasis to the parotid lymph nodes
ix. Complications
– Facial paralysis
– Frey’s syndrome (gustatory sweating): results when the
postganglionic parasympathetic nerve fibers of the parotid
gland aberrantly reinnervate the sweat glands of the skin.
Tx with Botox or insertion of Alloderm between skin and
deeper tissues
F. CONGENITAL
1. Embryology of the face
a. Face develops during weeks 3–8 of gestation
i. Frontonasal prominence: forms forehead and apex of nose
ii. Medial nasal prominences: forms primary palate, central maxilla
(premaxilla), nasal tip, columella, philtrum, central nose, septum
iii. Lateral nasal prominences: nasal ala
iv. Maxillary prominences: secondary palate, lateral maxilla, lat-
eral upper lip
vi. Mandibular prominences: mandible, lower lip, lower face
2. Etiology of craniofacial anomalies (theories of growth)
a. Fusion of processes (classic theory)
i. Facial prominences grow toward one another and fuse
ii. Failure of fusion results in facial clefts
b. Mesodermal penetration
i. Face consists of an ectodermal membrane with epithelial
seams demarcating the prominences
ii. Elevations and depressions in embryo occur with mesodermal
penetration between ectoderm and endoderm
iii. Failure of mesodermal penetration results in facial clefts
3. Craniofacial clefts
a. Tessier clefts
b. Oronasal clefts (Cleft no. 0–3)
i. Occur between the midline and Cupid’s bow, disrupting lip and
nose
– Cleft no. 0
• Directly in midline of lip and nose
• Can continue as cleft no. 14
– Cleft no. 1
• Through lateral margin of Cupid’s bow and into the nose
through parasagittal dorsum
• Subtype of nasal dysplasia
• Can continue as cleft no. 13
– Cleft no. 2
• Through lateral margin of Cupid’s bow into middle third of
nostril
• Deficiency and flattening of nasal soft tissue
• Can continue as cleft no. 12
• Extremely rare
– Cleft no. 3
• Can be unilateral or bilateral
• Originates from lateral margin of Cupid’s bow across
base of nasal ala and extends through nasolacrimal duct
and into lacrimal groove
• Can continue as cleft no. 10 or 11
c. Oral-ocular clefts (cleft no. 4–6)
i. Occur lateral to Cupid’s bow, extending through soft tissues of
cheek and maxillary process
ii. Connect the oral and orbital cavities w/o disrupting the nose
– Cleft no. 4
• Anatomically disruptive cleft and complex
• Unilateral, bilateral, or combined with other clefts
• Starts lateral to Cupid’s bow between commissure of
mouth and philtral crest, extends lateral to nasal ala and
terminates in lower eyelid medial to the punctum
• May involve lower canaliculus
• Usually preserves medial canthus and lacrimal sac
– Cleft no. 5
• Lip is cleft medial to the commissure, extending into the
lateral third of the lower eyelid
• Rarest oro-ocular cleft
– Cleft no. 6
• Starts lateral to oral commissure and extends to lateral
third of lower eyelid
• Associated with coloboma (soft tissue deformity in the
lateral third of lower eyelid, lower eyelid notching)
• Hypoplastic lateral malar region
• Includes mild forms of Treacher Collins syndrome
d. Lateral facial cleft (cleft no. 7–9)
– Cleft no. 7
• Most common craniofacial cleft
• 10% bilateral
• May be due to stapedial artery occlusion during
embryogenesis
• Starts at lip commissure and extends toward the ear
• Variable degrees of bony and soft tissue deformities
• Mandible, maxilla, zygoma, and middle ear affected
• Associated with microtia
• Hemifacial microsomia (also known as Goldenhar/Oculo-
Auriculo-Vertebral Spectrum [OAV])
– Cleft no. 8
• Isolated to lateral orbital region involving zygomatic fron-
tal suture
• Lateral canthal irregularity
• Associated with Goldenhar/OAV
• Extremely rare
– Cleft no. 9
• Involves superolateral orbit, dividing lateral third of
upper eyelid and brow
• Superior orbital rim and temporal bone involvement
• Associated with encephalocele
• Extremely rare
e. Treacher Collins syndrome
i. Bilateral cleft 6, 7, 8
ii. Autosomal dominant
iii. Soft tissue and skeletal hypoplasia
iv. Absence of zygomatic arch and lateral inferior orbital rim (max-
illary bone)
v. Hypoplastic mandibles
vi. Severe neonatal airway obstruction (most require tracheostomy)
4. Cranial clefts
a. Clefts involving the frontal bone above the orbit and skull base
b. Can be extensions of the midface clefts (cleft no. 10–14)
– Cleft no. 10
• Combined with cleft no. 4
• Central upper lid, brow, and orbit
• Coloboma present in upper lid
• Bony defect may include encephalocele
• May have hypertelorism
– Cleft no. 11
• Combined with cleft no. 3
• Medial eyebrow and upper lid deformity
• Bony defect through cranial base extending into ethmoid
sinuses
• Bony defect may include encephalocele
• May have hypertelorism
– Cleft no. 12
• Combined with cleft no. 2
• Disruption of medial eyebrow
• Bony defect of frontal bone extending down to nasofron-
tal buttress to pyriform rim
• Encephalocele and hypertelorism
– Cleft no. 13
• Extension of cleft no. 1
• Bony defect through olfactory groove and widened cribri-
form plate
– Cleft no. 14
• Midline facial cleft and CNS abnormalities
• Combined with cleft no. 0
• Hypertelorism and cranium bifida may occur
• Frontonasal encephalocele
• May have cyclopia
• Holoprosencephaly: hypotelorism, microcephaly, and
severe CNS disturbance
• Poor neonatal life expectancy
5. Reconstruction of facial clefts (typically involves multiple stages over
many years)
a. Early soft tissue closure (within first year)
i. Removal of scar within cleft
ii. Layered closure of soft tissues including muscles
b. Delayed skeletal reconstruction
i. Variable age
ii. Dependent on severity of skeletal defect and growth
c. Goals of reconstruction
i. Correct macrostomia if present
ii. Eyelid reconstruction to protect globe
iii. Repair facial musculature
iv. Separate orbital, nasal, and oral spaces
v. Attempt aesthetic correction of deformity
vi. Consider external ear reconstruction if microtia exists
6. Cleft lip and palate
a. Cleft lip (CL)
i. Epidemiology
– Incidence
• Race
○ 2.1/1000 in Asians
○ 1/1000 in Caucasians
○ 0.41/1000 in blacks in North America
○ Isolated cleft palate (CP) relatively constant at 1/5000
among races
• Type
○ 46% cleft lip and palate (CLP); 33% isolated cleft
palate; 21% isolated cleft lip
• Location of cleft lip: 6 (left); 3 (right); 1 (bilateral)
• Gender
○ Males: cleft lip and palate most common (2:1 relative
to females)
○ Females: isolated cleft palate most common
ii. Etiology
– Multifactorial risk factors (genetic and environmental factors)
– 20–50% may be associated with a genetic contribution
(nonsyndromic clefts)
– Increased parental age (>30, esp. father)
– Genetics
• 2% of nonsyndromic cases are hereditary
• 50% of syndromic cases are hereditary
• Multiple gene mutations identified (FGFR, TWIST, TGF-B,
MSX2, etc.)
ii. May cause increased intracranial pressure (ICP)
– Single suture involvement: up to 30% incidence increased
ICP
– Multiple sutures: 42% incidence increased ICP
– Potential sequelae of increased ICP
• Neurocognitive/psychomotor developmental delay
• Optic atrophy and vision changes/loss
• Gradual but irreversible process
• Difficult to predict which patients will develop increased
ICP and developmental delay
g. Diagnosis
i. Clinical exam: classic features of head shape
– Deformities are present at birth and will not autocorrect
ii. Verification with CT scan with 3D reconstructions (helpful for
educating parents and surgical planning)
h. Classification of single suture craniosynostosis
i. Sagittal
– 50% of all craniosynostosis cases (most common form)
– Results in scaphocephaly (dolichocephaly)
• Increased AP length
• Decreased bitemporal/biparietal/bioccipital width
– M:F ratio = 4:1
– Surgical correction (3–6 months of age)
• Goals: decrease AP dimension of skull and increase
transverse width of skull
• Options
○ Open approach: near total calvarial vault remodeling
for bitemporal, parietal, and occipital contouring (i.e.,
modified pi procedure with barrel stave osteotomies)
• Either via full coronal incision or limited incision
techniques
• Limited incision techniques benefit from postoperative
helmet molding for several months to optimize results
○ Endoscopic approach
• Must be combined with postoperative helmet molding for
several months to optimize results
ii. Coronal
– Unicoronal
• 20% of craniosynostosis
• Morphology: results in anterior synostotic plagiocephaly
○ Ipsilateral forehead flattening and superior orbital rim
retrusion
v. Kabuki syndrome
– Congenital mental retardation with additional features
such as
• Postnatal dwarfism, long palpebral fissures with eversion
of lower third of lower eyelid (hence Kabuki, a reference
to a form of traditional Japanese theater), large prominent
earlobes, cleft or high-arched palate, scoliosis, short fifth
finger, infantile otitis media, and radiographic anomalies
of hands, hips, a/o vertebrae
vi. Möbius syndrome
– Bilateral palsy of CN VI (abducens) and VII (facial)
– Other CN (III, V, IX, XI, XII) very rarely involved
– Up to ¼ of patients also have limb anomalies (syndactyly,
clubfeet, etc.)
vii. Nager syndrome (acrofacial dysostosis)
– Treacher Collins-type dysostosis + absent radius, radioul-
nar synostosis, and thumb hypoplasia/aplasia
viii. Pierre Robin sequence
– Triad of microretrognathia, glossoptosis, and upper airway
obstruction
– Often associated with Tessier no. 7 cleft (macrostomia)
– Thought to result from tongue abnormally interposing between
palatal shelves in utero
– Options to manage airway obstruction include (in order
of severity): positioning, lip-tongue adhesion, distraction
osteogenesis, a/o tracheostomy
– Patients often have feeding difficulties, and may require
tube feeding
ix. Romberg disease (progressive hemifacial atrophy)
– 95% unilateral; may affect any or all tissues in face (bone,
cartilage, skin, fat, etc.)
– Typically begins in first 2 decades of life, usually stabilizing
after several years
– Injectable fillers or grafts may help with mild cases whereas
advanced cases benefit from free flap reconstruction
x. Treacher Collins syndrome (mandibulofacial dysostosis)
– Gene 5q32-q33.1, autosomal dominant
– Combination of Tessier cleft no. 6, 7, and 8
– Features antimongoloid eye slant, lower lid coloboma, micro-
gnathia, microtia, zygomatic arch hypoplasia, macrostomia
– Often includes cleft palate a/o conductive hearing loss
xi. Van der Woude syndrome (lip-pit syndrome)
– Gene 1q32–q41
– Autosomal dominant
– Most common cleft syndrome
– Lower lip pits a/o sinuses, and cleft lip a/o cleft palate
ii. Goals
– Creation of a normal appearing external ear (very difficult to
achieve)
iii. Options
– Autologous costal cartilage grafting
• Modification from original techniques popularized by
Brent and Nagata. Recommend: Bauer BS, Plast Reconstr
Surg, 2009;124(1Supp):143–26e
• Create a subcutaneous pocket and rib cartilage
framework
• Involves multiple staged procedures
• Steep learning curve with autologous reconstruction
– Porous polyethylene (Medpor) implant
• Requires temporoparietal fascia flap for implant cover-
age with skin grafting
– Osseointegrated implant with custom prosthetic
• Requires experienced prosthetist to fabricate ear
9. Facial masses
a. Midline: image with CT before invasive procedures
i. Embryology: the fonticulus frontalis is transiently open between
the frontal and nasal bones. Additionally, a space between
the nasal bones and nasal cartilage (which later becomes the
foramen cecum) is briefly open as well. Failure of closure of either
of these spaces can lead to sinus tract a/o dermoid formation
ii. Dermoid cyst: most common, contains sebaceous material,
may communicate with intracranial space
iii. Encephalocele: herniation of brain through skull defect (from
one of the two spaces above), covered by dura and communicat-
ing with CSF
iv. Glioma: glial neural tissue, not covered by dura
10. Prominent ears
a. Pathoanatomy: one or more of the following
i. Antihelical fold relatively undeveloped
ii. Concha prominent
iii. Earlobe protruding
b. Surgery
i. Usually delayed until at least 4 years of age
ii. Techniques for components
– Antihelical fold: conchoscaphal (Mustardé) sutures, ante-
rior (Stenstrom) abrasion, parallel incisions along antihelix
(Converse–Wood-Smith)
– Conchal prominence: conchoids sutures to mastoid fascia
(Furnas), partial/crescent conchal excision
G. AESTHETICS
1. Evaluate
a. As a whole and in thirds
i. Forehead, midface, and lower jaw and neck
2. Rhinoplasty
a. Nasal anatomy
i. Aesthetic subunits: four basic components: bony vault (upper third);
vault (middle third); nasal tip/base (lower third); nasal septum
– Also assess chin (nose, lip, chin in relation to Riedel plane);
to create balance, a chin implant, genioplasty, or orthogna-
thic surgery may be beneficial
– Nasolabial angle: 90–105° (males), 100–120° (females)
4. Blepharoplasty
a. Upper blepharoplasty
i. Anatomy
– Outer lamella
• Skin 0.5–0.7-mm thick (thinnest in the body)
– Middle lamella
• Levator palpebrae: innervated by CN III
• Müller’s muscle: innervated by sympathetics
– Inner lamella
• Conjunctiva
• Fat found in medial and lateral components. Medial fat
paler.
ii. Evaluation
– With what is the patient unsatisfied?
– Medical history: renal, cardiac, thyroid dz, sx of myasthenia
gravis
• Blepharochalasis: recurrent bouts of upper lid edema—
contraindication to surgical intervention
• Dermatochalasis: excess skin in the upper lid
– Hooding
– Scleral show: no scleral show should be seen below the infe-
rior limbus pre- or postoperatively—sign of ectropion
– Brow position:
• Male: flatter brow with position at superior orbital rim;
• Female: 1 cm above the orbital rim, arch should be pres-
ent with peak between lateral corneal limbus and lateral
commissure
– Schirmer’s test: test to assess adequate eye tear production
(normal is greater than 15 mm on filter paper)
– Assess levator function and assess for preoperative ptosis:
upper lid should only cover 1–2 mm of upper limbus
iii. Visual acuity and visual fields
iv. Surgery
– Marking: in upright position; calipers for precise measure-
ments; lower border corresponds with upper margin of
tarsus (usu. 8–10 mm above ciliary margin); upper border
determined by pinch
– Anesthetic: local versus sedation
– Technique: usu. excise skin with strip of orbicularis, skin and
medial and middle fat compartments ; bulging laterally indi-
cates lacrimal gland ptosis (suspend, don’t resect gland)
– Postoperative: ocular pain could indicate retrobulbar
hematoma and should be addressed immediately (ste-
roids, acetazolamide, removal of sutures, decompression of
hematoma, elevation)
A. ANATOMY
1. Osteology
a. Carpus: eight carpal bones aligned in two rows along Gilula’s lines
i. Proximal row (radial to ulnar), forms radiocarpal and ulnocarpal
joints, convex/concave
– Scaphoid
– Lunate
– Triquetrum
– Pisiform
• Situated palmar to the above three; pisotriquetral joint is
separated from adjacent articulations
• The hamate contributes to ulnar boundary of the carpal
tunnel; the pisiform forms the ulnar border of Guyon’s canal
ii. Distal row (radial to ulnar), forms midcarpal joint (normally
does not communicate the radiocarpal joint), and also articu-
lates with five metacarpals, relatively straight
– Trapezium
• Articulates with thumb metacarpal at the carpometacar-
pal joint (a saddle joint)
• The trapezial ridge along with the scaphoid tuberosity
form the radial boundary of the carpal tunnel
– Trapezoid: the trapeziotrapezoid joint can be involved with
pantrapezial arthritis and deserves inspection during thumb
carpometacarpal (CMC) arthroplasty
– Capitate
– Hamate: there is more motion at the ring/small finger CMC
joints that facilitates power grip on the ulnar aspect of the
hand
b. Metacarpals
i. “Stable portion” of hand formed by second and third metacar-
pals which act as single osseoligamentous unit
ii. Mobile portion of hand formed by fourth and fifth metacarpals
which also are responsible for “power grip”
c. Phalanges
d. Joints
i. Radiocarpal
ii. Distal radioulnar joint (DRUJ)
iii. Intercarpal and midcarpal
iv. Carpometacarpal
v. Metacarpophalangeal (MCPJ)
6. Ligaments
a. Collateral ligaments
i. Metacarpophalangeal joint (MCPJ)
– Quadrangular, symmetrical; cam shape of metacarpal head
keeps them taut in flexion, lax in extension
– MCPJ should be immobilized in flexion to avoid stiffness
ii. Interphalangeal joints (IPJs)
– Proper collateral ligament inserts onto phalangeal base,
more volar accessory collateral ligament onto volar plate
– IPJs should be immobilized in extension to avoid stiffness
• Zone 3 = PIPJ
○ Usually from forced flexion of PIP joint with avusion of
central slip from its insertion on dorsal base of middle
phalanx (+/− avulsion fx)
○ Boutonnière deformity results from avulsion of
central slip with resultant PIP joint flexion and DIP
hyperextension
○ Begins with PIP flexion from unopposed FDS action,
followed by stretching of expansion (transverse reti-
nacular and triangular ligaments) between central and
lateral slips. Lateral bands migrate to become volar
to axis of joint rotation, allowing intrinsic muscles to
pull exclusively on distal joint, hyperextending it. Most
often gradually develops 1–3 weeks after injury
○ Dx
■ As boutonnière deformity is generally delayed, dx
should be suspected with recent injury resulting in
swollen, painful PIP joint with limited ROM, main-
tained in semiflexed position
■ Elson test: passively flex PIP joint over table edge
and maintain in place; ask patient to actively extend
PIP against resistance—any perceived (by exam-
iner) pressure over middle phalanx indicates intact
(at least partially) central slip
○ Tx
■ Closed boutonnière
□ Acute: progressively splint PIP joint into full
extension and/or place oblique transarticular
K-wire to maintain PIP joint in extension. Keep
passively actively ranging DIP joint. Typically do
for 6 weeks. Indications for operation: central slip
avulsion fracture (replace or excise fragment and
reattach tendon with a pullout suture); young per-
son with long-standing boutonnière deformity
■ Central slip laceration at PIP joint: repair with modi-
fied Kessler suture with 4–0 suture, beginning 1 cm
from tendon laceration edge; follow with 5–0 suture
Silfverskiold cross-stitch from margin to margin of
extensor. Suture anchors have aided with repair of
open zone 3 extensor laceration to the central slip
• Zone 4 = over proximal phalanx, primary repair with hori-
zontal mattress or other technique
• Zone 5 = MCPJ, primary repair with horizontal mattress
or other technique
○ Sagittal band injuries: repair if identified
B. EVALUATION
1. History
2. Physical
(See Table 3.1)
3. Radiography
a. Three standard views
i. Frontal (PA): hand flat, palm down, forearm pronated
ii. Oblique: from PA position, supinate hand 45° (step sponge
helps maintain IP joint orientation/spread)
iii. Lateral: hand rotated further into radioulnar projection with
fingers spread
v. Thumb metacarpal fx
– Diaphyseal: uncommon, and because of the thumb’s con-
siderable CMC motion, dorsal angulation relatively less
important functionally than in the fingers (up to 30° usually
tolerated, although not aesthetically)
• Immobilize in CMC abduction and extension w/slight MCP
flexion and IP extension. Difficult to control nonopera-
tively given tendon pull. CRPP preferred over ORIF
– Base
• Extraarticular epibasilar: tx like diaphyseal fx (most often,
closed is acceptable)
• Intraarticular: challenging
○ Bennett’s (intraarticular) fx: CRPP versus ORIF. If
ORIF, use Wagner incision/exposure. If fragment large
enough, can use screws
○ Rolando’s fx: a comminuted intraarticular fracture of
the base of the thumb metacarpal (originally described
as having a Y- or T-shaped intraarticular component)
• In those with Y- or T-shaped intraarticular components,
ORIF w/K-wires, plates, and screws indicated. Fixed
angle plates (i.e., miniblade plates or locking plates) may
be advantageous
• In more comminuted fx, additional techniques such as
skeletal traction and mini-external fixators may be useful
c. Proximal phalanx
i. Closed management
– After nerve block, apply longitudinal traction if shortening
present, then correct deformity
– Deforming forces of intrinsic muscles can be minimized
with flexion of MCP
– Test stability of reduction and rotational alignment.
Tenodesis maneuver is performed and digital cascade is
compared to the contralateral side.
– Obtain post reduction radiographs
– Radial or ulnar gutter splint may be appropriate for
immobilization
• Alternatively, immobilize wrist/hand in extension with
reduced digit on outrigger splint w/MCP flexed 90°, PIP
extended
• Facilitates visual and radiographic evaluation of alignment
• Stable, minimally displaced, appropriately aligned fx’s
may be managed by taping/strapping to adjacent finger
and permitting protected motion relatively early
– Intrinsic plus position: diminishes deforming forces of
intrinsic muscles and avoids MCP/PIP collateral ligament
contracture
• Wrist extended
• MCP flexed to 70–90°
• PIP extended
• 3–4 weeks after reduction, begin (protected) motion, w/
continued splinting prn
– Periarticular (PIPJ): requires reduction and stabilization.
Dynamic external fi xation can be helpful in complex articu-
lar fractures of the base of P2 (i.e., “pilon fractures”)
– Periarticular (MCPJ): internal fixation with protected early
motion recommended
– Diaphyseal: tend to angulate apex volar due to intrinsic
muscles and extensor mechanism
• Reduce by applying axial traction pulling on flexed MCP,
accentuation of deformity to disengage fragments, then
correct
• Tx: CRPP versus ORIF
d. Middle phalanx
i. Closed management principles generally the same as for proxi-
mal phalanx fx
ii. Nondisplaced, extra articular: buddy tape 3–4 weeks. Spiral fx
are rotationally unstable and often require fixation, CRPP ver-
sus ORIF.
iii. Displaced a/o articular: unstable fx
iv. Dorsal fx subluxation of PIP: treatment predicated on size
of volar articular fragment; <30% articular surface stable,
30–50% tenuous, >50% unstable
v. Extremely disabling, comminuted, unstable fx – tx options
– Dynamic traction to maintain reduction while permitting
joint motion useful for complete articular pilon fractures
– Dorsal block splinting in a degree of flexion to maintain
concentric reduction: gradually extend the splint angle over
4–5 weeks, useful when PIPJ joint reduced and concentric
in flexion
– Late injury may require volar plate arthroplasty versus
hemi-hamate arthroplasty
– Cases involving the thumb may be managed with thumb
spica cast or splint or ORIF w/ K-wires, plates, a/o screws
e. Distal phalanx (most common hand fx)
i. Tuft: often associated with subungual hematoma
– Drain subungual hematoma if painful
– If significant damage to nail/nail bed, consider repairing
bed with fine absorbable suture
– If nail is not too damaged, consider replacing as a biologic
stent
– Physical findings
• Tenderness just distal to Lister’s tubercle
• Watson shift test positive
– Acute (within 3 months of injury) and reducible
• Repair scapholunate ligament and buttress with dorsal
capsulodesis
○ Ligament reconstruction with FCR tendon (Brunelli-
type reconstruction), bone ligament bone construct,
“Reduction and Association of the Scaphoid and
Lunate” (RASL) procedure are other options
– Chronic (after 3 months of injury) irreducible
• Untreated dorsal intercalated segment instability (DISI)
pathology can degenerate into scapholunate advanced
collapse (SLAC) wrist over time
• Ligament cannot be repaired, and arthritic changes often
present
• Options
○ Proximal row carpectomy: good pain relief, (usu.) w/
preservation of ~75% grip strength and ~55% ROM
versus scaphoid excision with four-corner fusion
○ Wrist arthrodesis: consider if lunate fossa of radius or
capitate head are arthritic
F. TUMORS
1. General
a. When operating on upper extremity malignancies, do NOT use
Esmarch before tourniquet; instead, elevate the arm and compress
brachial artery for 1 minute
2. Soft tissue
a. Benign
i. Ganglia: most common soft tissue tumor of the hand
– Location
• Dorsal (~70%): most often from scapholunate ligament
• Volar (~20%): most often from radiocarpal joint or sca-
photrapezial joint capsule
• Can also occur along flexor tendon sheath of A1 pulley,
termed retinacular ganglion
iii. Diagnosis
– Nerve conduction studies (NCS)
• Latency is measured in milliseconds (msec)
○ Most commonly used in evaluating carpal tunnel
syndrome
• Velocity measured in meters per second (m/sec)
○ Most commonly used in evaluating cubital tunnel
syndrome
• 10+ m/sec decrease in velocity at elbow is clinically sig-
nificant; ulnar motor CV <40 m/sec unlikely to respond to
nonoperative management
• Electromyography: useful for diagnosis of denervation
and myopathies
– Brachial plexus injury features
• Loss of motor function (motor neuron cell bodies in ven-
tral horn of spinal cord) with preservation of sensory
H. CONGENITAL
1. Embryology
a. Limb bud differentiates between weeks 3 and 8
b. Three critical regions for differentiation
i. Apical ectodermal ridge (AER): controls mesodermal differen-
tiation, governs proximal to distal growth
– Secretes fibroblast growth factor. Disturbance may result in
conditions such as transverse arrest and syndactyly
– Dorsal ectoderm: controls dorsal to palmar differentiation
via dorsalizing factor Wnt-A
– Zone of polarizing activity (ZPA): controls anterior to pos-
terior development, regulated in part by secretion of sonic
hedgehog (Shh) protein secreted by posterior part of limb;
disturbance may result in condition such as ulnar dimelia
2. Classifi cation (Swanson) (Swanson AB, Swanson GD, Tada K, J Hand
Surg Am. 1983 Sep;8(5 Pt 2):693–702)
a. Failure of formation (I)
i. Transverse arrest
– Most commonly occurs just below elbow to upper 1/3 of
forearm
– Phocomelia: condition in which limb is abnormally short
• Complete: hand attached directly to trunk
• Proximal: proximal segment missing, forearm attached to
trunk
• Distal: hand attached to arm
– Robert syndrome: tetraphocomelia (similar to thalidomide
embryopathy) + CNS and craniofacial anomalies
ii. Longitudinal arrest
– Radial
• Radius
○ Classification
■ Type I: short distal radius
■ Type II: hypoplastic radius
■ Type III: partial absence of radius
■ Type IV: complete absence of radius
○ Treatment
■ First, evaluate for VACTERL, TAR syndrome, Fanconi
anemia, Holt-Oram, etc.
I. OTHER
1. Tourniquet and Esmarch
a. After prepping extremity, wrap upper arm with three rolls of Webril,
then place tourniquet over Webril only with two valves pointing out
of field toward machine. Wrap 1000 drape circumferentially with
adhesive over skin as well as distal edge of cuff with drape oriented
proximally. Wrap Esmarch from fingers to tourniquet, then inflate tour-
niquet to 50–75 mm Hg above patients systolic pressure; 250 mm
b. Hg is standard (may be higher for obese, atherosclerotic patients,
etc.). Can preset tourniquet to this pressure and time to alarm
(i.e., set at 90 min if desire no more than 2 hours ischemia). Two
hours is time limit to avoid muscle and nerve injury. For prolonged
operations, the tourniquet should be released 5 minutes for every
30 minutes of use. If suspected malignant or infectious lesion in
the extremity, do NOT use Esmarch to exsanguinate; rather, elevate
the extremity and compress brachial artery for 1 minute
A. ANATOMY
1. Perfusion: superficial collateral flow from second/third interspace IMA
perforator; additional deep flow predominantly from IMA perforator at
fifth/sixth interspace
2. Innervation: majority of sensation to nipple-areolar complex (NAC)
from lateral branch of the fourth intercostal nerve
B. RECONSTRUCTION
1. Goals: restore components of breast after complete or partial
mastectomy
2. Considerations: timing (immediate, delayed), patient habitus and
prior surgery, adjuvant therapy (XRT, chemo)
3. Immediate versus delayed
a. Immediate
i. Advantages
– Superior result particularly with autologous (no patch
effect)
– No scar tissue to complicate reconstruction
– Reduced anesthetic risk
– Reduced costs
– Improved immediate body image
ii. Disadvantages
– Decision made at time of stress
– Increased risk of complications (infection, implant expo-
sure, mastectomy flap necrosis)
b. Delayed
i. Advantages
– Patient has time to consider alternatives
– Avoids reconstruction complication potentially delaying
chemotherapy
ii. Disadvantages
– Adjustment period of dealing with loss of breast then
accepting breast as own
4. Autologous versus prosthesis-based
a. Autologous: use of woman’s own tissue (skin, muscle, fat) from
another part of the body (flap reconstruction)
i. Advantages
– May eliminate use of foreign material
– Usually looks and feels more natural
– Lifelong reconstruction
– If successful, minimal additional surgeries
ii. Disadvantages
– Increased complexity and length of surgery
– Longer recovery
– Risk of donor site complication
– Smokers, women with vascular or connective tissue dis-
eases, and diabetes are at increased risk of wound-healing
complications
– Some women may also require an implant for adequate
volume
iii. Adjuvant therapy
– Irradiation (XRT)
• Conservative therapy encompasses wide localized exci-
sion (WLE), axillary lymph node dissection (ALND), and
irradiation postmastectomy radiation therapy (PMRT)
• Considered when risk of local recurrence >20%
○ >three axillary lymph nodes
○ Tumor size >4 cm
○ T4 disease and close/+ margin
iv. Autologous reconstruction preferred after healed from XRT
– Transverse rectus abdominis myocutaneous (TRAM)/deep
inferior epigastric perforator (DIEP) flap
– Latissimus dorsi (LD) flap
v. Tissue expander reconstruction less ideal
– XRT after completion of expansion if possible
– Avoid expanding radiated skin
– XRT increases complications (infection, capsular contrac-
ture, implant exposure)
vi. Chemotherapy
– Surgical timing
• Wait at least 1 month for any staged procedure
○ Allows immune system recover
• Check CBC (r/o leukopenia, anemia, thrombocytopenia)
– Herceptin: cardiotoxic, consider cardiology consult
vii. Autologous options
– Pedicled flaps
– LD flap
* Note: With the unusual exception of the extended latissimus flap, this option
almost always requires prosthesis for volume.
• Most often reserved for patient with unsuitable skin for
implant alone (e.g., post-XRT)
• Blood supply thoracodorsal artery (1–2 mm diameter)
• If thoracodorsal artery severed LD flap is supplied by ser-
ratus branch via intercostal arteries/collateral vessels
• Flap width: average 7 cm, may be up to 12 cm depending
on body habitus
C. REDUCTION MAMMOPLASTY
1. Indications: many insurance companies identify criteria such as 500 g
excess mass per breast, bra strap notching, or inframammary fold
(IMF) rashes for reimbursement
2. Average measurements
a. Sternal notch-to-nipple distance: 21–23 cm
b. Nipple-to-IMF distance: 5–7 cm
c. Nipple-to-sternal distance: 9–11 cm
3. Risk factors for need for free nipple graft: nipple to IMF 18 cm,
sternal notch to nipple 30 cm
4. Risks
a. Diminished NAC sensation: lateral cutaneous branch of fourth
intercostal nerve; nerve runs along pectoralis fascia (preserve fat
layer above)
b. NAC necrosis
i. Usually noticed within 48 hours postoperatively, but may occur
7–10 days later in smoker
ii. If impending necrosis hyperbaric oxygen/leeches may help
– Delay débridement
– Minor loss of areola → tattoo
– Loss of nipple → standard nipple reconstructive technique
– Total loss of nipple-areola
• Increased risk of pedicle loss
○ Fat grafting
○ Autologous reconstruction
c. Effects on breastfeeding
i. 50–70% chance of nursing postoperatively
D. AUGMENTATION
1. Choice of implant
a. Size: mainly determined by breast width and projection in conjunc-
tion with patient desires
i. Larger implants prone to ptosis more quickly
b. Fill material
i. Silicone: more natural feel, less prone to “wrinkled” appear-
ance in thin women
ii. Saline: may be less expensive, may provide increased upper
pole fullness; main recommendation is for women who fear
silicone implants or silent ruptures
c. Implant shell surface: textured versus smooth surface
i. Advantages
– Smooth surface: less rippling and palpability
– Textured: tissue integration (important for anatomic shaped
implants)
d. Implant shape: anatomic versus round
e. Implant profile: moderate, moderate plus, and high profile (Mentor)
versus low, medium, high, and extra high profile (Allergan)
2. Choice of approach
a. Periareolar
i. IMF (inframammary): most common approach, easy to learn
ii. Axillary/endoscopic: reliable approach with use of endoscope
iii. Transumbilical breast augmentation (TUBA): higher revision
rate and lower satisfaction score
3. Choice of placement
a. Subglandular: higher rates of capsular contracture and rippling
b. Submuscular (under pectoralis muscle): dual-plane; partial sub-
muscular (types 1, 2, 3): depends on degree of muscle release from
overlying breast parenchyma
4. Risks
a. Capsular contracture
i. Hyperimmune response to the foreign body (i.e., implant)
resulted in thickening, tightening, or the implant capsule
resulting in various degrees of deformity and possibly pain
ii. Grading of capsular contracture: Baker’s classification (Spear
SL, Baker JL, Jr., Plast Reconstr Surg. 1995 Oct;96(5):1119–23)
– Baker’s 1: soft capsule, appear natural
– Baker’s 2: capsule if firm/hardened, but the breast appears
natural
– Baker’s 3: hard, thickened capsule with distorted-appear-
ing breast
– Baker’s 4: hard capsule with very distorted breast and pos-
sible associated pain
iii. Prevention of capsular contracture: sterile no-touch technique,
placement of implant in submuscular position, triple antibi-
otic solution irrigation (Adams WP Jr, Rios JL, Smith SJ, Plast
Reconstr Surg, 2006;117(1):30–6), and occlusive dressing over
the nipple
iv. Treatment of capsular contracture
– Medical: accolate, singulair, flector patch—possible treat-
ment options, but no proven benefit; all anecdotal
– Surgical: complete capsulectomy with placement of a new
implant in the submuscular position
b. Hematoma: should be surgically addressed with complete evacua-
tion of clot, consider pulse lavage to minimize secondary capsular
contracture
c. Infection
i. Prevention: single dose of IV cefazolin or vancomycin prior to
surgery, no-touch technique, triple antibiotic solution
ii. Tx: cellulitis—trial of oral, then IV abx. If fails, explantation,
wait 3 months, and repeat augmentation; implant salvage
has been described (Spear SL, et al., Plast Reconstr Surg,
2004;113(6):1634–44)
B. AESTHETIC
1. Massive weight loss patients
a. Metabolic workup
i. Weight loss surgery at least 12 months prior, weight stable for
3–6 months
ii. Check iron, folate, B12, albumin, and prealbumin
b. High risk for wound complications and thromboembolic events:
don’t commit to surgery >6 hours
c. Weigh risks and benefits of heparin SQ prophylaxis
d. Protein supplementation before and after surgery
2. Liposuction
a. Tumescent solution or superwet: most appropriate with 1% blood
loss; wet and dry have much higher rates of blood loss
b. Endpoints: >4 L, bloody aspirate, or satisfied with pinch test
c. Fluid resuscitation: generally 2 × aspirate = tumescent + IVF
d. Cross-tunneling to prevent contour deformities: larger cannulas
more prone to contour deformities
3. Abdominoplasty
a. Full: involves resection of fat/skin, repositioning umbilicus, and
plication of diastasis +/− liposuction
b. Mini: plicates and excises exclusively below umbilicus, can involve
“floating” the umbilicus
c. Fleur-de-Lis: enables surgeon to recruit and excise additional lat-
eral tissue
d. Circumferential: if excess tissue in abdomen, flanks, but hips/
buttocks not sagging
e. Lower body lift: if hips, buttocks sagging, addresses lateral aspect
of hips
A. TRAUMA
1. Thigh: Adequately perfused soft tissue usually available for locore-
gional reconstruction.
2. Leg (if possible, provide definitive coverage within 1 week of injury)
a. Gustilo classification (developed for tibial injuries but frequently
applied to other anatomic areas)
i. Grade I: wound <1 cm, minimal soft tissue injury, minimal
comminution
ii. Grade II: wound >1 cm, moderate soft tissue injury, moderate
comminution
iii. Grade III
– Segmental fx with displacement
– Diaphyseal segmental loss
– Associated vascular injury requiring repair
– Farmyard injuries/highly contaminated wounds
– High velocity gunshot wound
– Crushing injury by fast-moving vehicle
• Grade IIIA
○ Wound >10 cm, crushed tissue, contamination, local soft
tissue coverage possible → nail, union minimal delay
• Grade IIIB
○ Wound >10 cm, crushed tissue, contamination, requires
regional or free flap → nail, union delay 25–30 weeks
• Grade IIIC
○ Major associated vascular injury requiring repair for
limb salvage
○ Fracture classified using mangled extremity system
score (MESS)
○ May be necessary to perform below the knee amputation (BKA)
b. Contraindications for salvage of Gustilo IIIC injury in lower extremity
i. Pre-existing severe comorbidity
ii. Tibial loss >8 cm
iii. Ischemia >6 h
iv. Severance of posterior tibial nerve in adults, or sciatic nerve in
anyone (increasingly controversial)
3. MESS: consider amputation if total score >7 (see Table 6.1).
Note: the original article that reported this threshold was retrospective.
Prospective data suggests that up to 1/3 of “nonsalvageable” limbs
may in fact be able to be salvaged with reasonable outcome.
4. Fasciotomy
a. Indication
i. Prophylactically if ischemia >4–6 h
ii. Compartment pressure >30 mm Hg or within 20 mm Hg of dia-
stolic pressure
iii. Clinical dx most suggested by disproportionate level of pain
on passive extension of compartment in conjunction with firm,
swollen extremity; paresthesias, coolness, diminished pulses
and pallor are considered to be inconsistent, late findings
5. Soft tissue reconstruction by region
*Notes: Free flap reconstruction should be preceded with angiogram in
cases of trauma or for a concern of atherosclerosis.
a. Consider end-to-side anastomosis in attempt to preserve distal
perfusion
b. Be aware of the rare but occurring peroneus magnus and other vas-
cular variants that may impact success
6. Thigh: usually adequate soft tissue for reconstruction
7. Knee
a. Gastrocnemius, distally pedicled anterolateral thigh (ALT) flap
8. Proximal 1/3 tibia
a. Gastrocnemius
9. Middle 1/3 tibia
a. Soleus, pedicled perforator fasciocutaneous (e.g., propeller flap)
iii. The Parkland, Brooke, and Galveston Formulas ALL use Ringer’s
lactate for the crystalloid, and ALL administer ½ the total fluid
volume over the first 8 hours post-injury (not post-hospital
arrival), with the second ½ total fluid volume distributed over
the ensuing 16 hours. Follow clinical findings to avoid under-
or over-resuscitation. Also, in infants and children less than
30 kg, recommend running a second for maintenance fluid with
D5LR to avoid hypoglycemia
d. Urine
i. UOP: maintain ≥30 cc/h (30–50 ideal) (0.5 cc/kg/h) for adults
or 1.0 cc/kg/h for children
ii. Alkalinization: high voltage burns, crush injuries with myoglo-
binuria/hemoglobinuria at risk of acute tubular necrosis (ATN)
– Not necessary to treat microscopic myoglobinuria, just
grossly obvious cases. Consider use of mannitol and/or
sodium bicarbonate for these patients (i.e., 2 amps sodium
bicarbonate and 25 mg mannitol IV prn)
iii. Other adjuncts
– In the intensive care setting, pediatric patients may benefit
from reducing the hypermetabolic demands on the heart by
treatment with beta-blockade (i.e., propanolol)
– Early use of albumin or excessive fluids required should
prompt placement of PA catheter. Burn patients are almost
always extremely hypermetabolic
4. Nutrition and electrolytes
a. Energy expenditure
i. Nonintubated: 629 – 11 (age) + 25 (wt in kg) – 609 (if obese)
ii. Intubated: 1925 – 10 (age) + 292 (if trauma) + 5 (wt in kg)
+ 281 (if male) + 851 (if >20% TBSA burn)
b. Begin nutritional support postburn day 1
c. Enteral feeds are preferred to parenteral nutrition
d. Only stop tube feeds if residuals are >150% of the hourly rate or
200 cc (whichever is more). Restart, then check again at 1 hour,
2 hours, then q 4 hours
e. Adults with >20% TBSA burns may benefit from anabolic medica-
tions such as oxandrolone
f. Burn patients are essentially psychogenic drinkers; follow their
sodium levels!
*Note: Gatorade, Pedialyte, and ice are restricted fluids regardless of sodium
level.
B. THERMAL BURNS
1. Initial patient considerations
a. Avoid hypothermia; wrap in blanket as necessary
b. Remove all jewelry and constricting items; edema will follow major
burns
c. Perform standard trauma assessment: AMPLE hx, PEx w/ neuro
exam, order CBC, chem 7, ABG, CXR, carboxyhemoglobin. Examine
extremity pulses (may need Doppler); if absent, consider escha-
rotomy (can do at bedside w/IV sedation down to but not into sub-
cutaneous tissue). Note that escharotomies do not always follow
the same skin incisions as fasciotomies. Escharotomy on chest
wall may be indicated if impaired ventilation or high pulmonary
pressures
2. Immediate wound considerations
a. Prehospital: copiously irrigate wound with water and protect with
clean dressing/sheet
b. Gently clean, débride loose skin and blisters (blister fluid is proin-
flammatory and a good culture medium). In reliable patients, may
leave intact blisters <1 cm undisturbed
c. Cover with topical antimicrobial (see following, in “Infection”) and
absorbent dressing
d. Accurately estimate burn size and depth (4% TBSA error translates
into 1-liter error in 70-kg patient on the first day)
i. Wallace’s rule of nines (for second- and third-degree burns, in
honor of A.B. Wallace, a Scottish plastic surgeon)
– Adult
• Head: 9%
• Upper extremity: 9%
• Neck: 1%
• Anterior trunk: 18%
• Posterior trunk: 18%
• Lower extremity: 18%
– Child
• Head/neck: 18%
• Upper extremity: 9%
• Anterior trunk: 18%
• Posterior trunk: 18%
• Lower extremity: 14%
Note: A patient’s palm (fingers included) is roughly 1% of his/her BSA.
ii. Tetanus prophylaxis: if burn >10% BSA, give 0.5 cc tetanus
toxoid. If tetanus immunization history >10 years ago, or if
received less than 3 total doses, or uncertain, also administer
250 units of tetanus immunoglobulin
– Both Td and TIG are given IM; in short, treat all burn wounds
like dirty wounds
3. Scald injuries
a. Most common form of burn injury in patients <5 yo
b. Unlike other burns that appear white or black (as well as dry and
leathery) with full-thickness burns, third-degree scald burns gener-
ally appear red (as well as dry and leathery)
4. Infection: leading cause of death in adequately resuscitated
patients
a. Mortality used to be from wound sepsis, but now pneumonia is main
risk
b. Generally don’t consider a fever significant in a burn patient unless
≥39.5°C as all patients will be hypermetabolic
c. Topical agents: indicated immediately after débridement (see Table 7.2)
C. INHALATION INJURY
1. Generally do not cause direct thermal injury below level of vocal
cords (exception is steam). Therefore, mechanism is from chemical
injury. Majority of house burn fatalities are from anoxia, not thermal
injury
2. Injury may mature up to 48 hours postexposure, and is generally
underappreciated initially
3. Pulse oximetry not accurate. Obtain ABG and carboxyhemoglobin
levels. If have high index of suspicion, treat with non-rebreather mask
oxygen, and sit patient up at 45° to minimize airway edema
a. CO level of 50–60% usually fatal
b. CO level >5% abnormal except in smokers (>10%)
c. Tx until <10% (non-rebreather mask decreases half-life from 240
min to 40 min)
d. Suspect cyanide toxicity if persistent metabolic acidosis despite
what should be adequate resuscitation
i. If have pulmonary artery catheter, may also see increased SvO2
(ddx: sepsis, hepatic failure, AV shunt, nitroprusside toxicity)
ii. Tx: amyl nitrite, sodium nitrite, followed by sodium thiosulfate
4. Bronchoscopy: indicated to document diagnosis, but can also be
therapeutic (suctioning plugs, etc.). Xenon diffusion scan alterative
means of diagnosis
5. Nebulized heparin (decrease cast formation) and acetylcysteine:
(loosen secretions, decrease oxygen toxicity) shown in one study to be
of benefit along with bronchodilators and aggressive pulmonary toilet
(Desai, MH, et al., J Burn Care Rehab, 1998, 19(3):210–2)
D. ELECTRICAL BURNS
1. Low voltage (<1000 V)
2. High voltage (>1000 V)
a. Neurologic: neurologic complications can develop early or late after
trauma including encephalopathy, hemiplegia, aphasia, and brain
stem dysfunction up to 9 months after injury
b. Cardiac: arrhythmias, particularly ventricular fibrillation can occur
c. Renal: myoglobinuria can induce acute tubular necrosis. The earli-
est sign of impending problems is a distinctive “cranberry” color
urine; once dark sediment is noted in the urine, more aggressive
treatment (beyond keeping up at 2 cc/kg/h) may be warranted.
Mannitol and sodium bicarbonate may be given in a variety of
methods. Some give a one-time dose of 25 mg mannitol and one
bicarb ampule. Others recommend 25 mg IV of mannitol q6h and a
5% continuous bicarb infusion titrated to urine pH
d. Extremity
i. Tetanic convulsions can lead to fractures/dislocations. Consider
use of c-collar until injury can be ruled out
ii. Fasciotomies (not just escharotomies) must be considered in
any extremities with tense compartments, circumferential
injury, rhabdomyolysis, or other evidence of muscle compro-
mise. Unlike flame burns, damage to deep tissues is much
greater than suggested by skin pathology, especially around
bone that serves as a heat sink for electrical current
e. Abdomen
i. Intraabdominal injury, including bowel perforation, can occur
f. Other
i. Cataracts develop in almost 1/3 of patients after high-voltage
injuries as a long-term complication
3. Lightning
a. May cause temporary (unlike high-voltage electrical injury) paraly-
sis (keraunoparalysis) and/or apnea
b. Evaluate for blast effect (burst tympanic membranes)
c. Can cause arborizing, dendritic burn pattern over skin with (often)
relatively spared internal tissues
E. CHEMICAL BURNS
1. General: remove clothing, copiously irrigate with (minimum
15 liters) water. Brush powders away before irrigation
2. Acids: irrigate with water, do not attempt to neutralize, tends to form
eschars
a. Hydrofluoric/oxalic/phosphoric acids: chelate calcium and magne-
sium, causing extensive, extremely painful local tissue destruction
and potential arrhythmias. Copious irrigation with water followed
by immediate application of calcium gluconate gel (2.5%), replac-
ing the gel every 15 minutes until pain is relieved is appropriate. If
significant pain persists after several cycles of gel change, intra-
dermal calcium gluconate (10% at 0.5 cc/cm2 involvement) may
be of use. Alternately, intraarterial calcium gluconate may be tried.
Failure to control the wound could lead to further extension of dam-
age, including demineralization of underlying bone. Admission for
telemetry monitoring (QT interval emphasis) is indicated, and 20
cc of calcium gluconate (10%) should be added to first liter of IV
fluid. Frequent monitoring of calcium, magnesium, and potassium
are indicated
b. Hydrochloric acid: fumes can cause pneumonitis
c. Dichromate salts: consider aggressive débridement (LD 50 is
50 mg/kg)
d. Sulfosalicylic/tannic/trichloroacetic acids: systemic absorption can
lead to hepato/renal toxicity
e. Formic acid: can cause considerable electrolyte abnormalities, met-
abolic acidosis, renal failure, ARDS, and hemolysis. Hemodialysis
may be required for large exposures. Wounds are characteristically
greenish, deeper than are initially apparent, and are optimally man-
aged by excision.
3. Bases (lime, bleach, sodium/potassium hydroxide): liquefactive
necrosis invades more deeply than acid burns
a. Irrigate with water, may take longer than with acids
b. Cement (calcium oxide) leads to similar injury from hydroxyl ion.
Irrigate (water/soap) until effluent has pH <8
4. White phosphorus: used in munitions and fertilizer. Spontaneously
ignites upon contacting air. Immediate management includes covering
with saline-soaked gauze (keep from air). Definite management includes
copper sulfate (0.5%) irrigation and removal of particulate matter/
foreign bodies
5. Hydrocarbons: wounds are typically superficial and heal w/o extensive
surgery, although ignition of the hydrocarbons would cause full-thick-
ness injury. Neosporin or bacitracin are useful to help remove residual
hydrocarbons. Systemic absorption, however, can result in respiratory
embarrassment and/or hepatic toxicity
vi. Face
– Large variety of burn facial deformities and surgical strate-
gies. Common complaints: color, texture, cheek tightness
masking facial expressions
– Stigmata frequently needing correction: include lower eyelid
ectropion; short nose with alar retraction or flaring; short,
retruded upper lip; lower lip eversion and inferior displace-
ment; flat facial features and loss of jaw line definition
– Solutions for extrinsic contractures superior to those for
suppleness of skin
– Two broad approaches
• 1: Scar remodeling: proponents assert facial burn scars
improve with time, and process is assisted through laser
(PDL or ablative), Z-plasties, and small skin grafts. They
claim facial subunits replacement with large flaps or
grafts trades one deformity for another
• 2: Scar replacement: proponents argue that remodeling
requires years, and advocate early, aggressive surgery
with flaps. While durable, flaps are bulky and are difficult
to match in color
G. FROSTBITE
1. Occurs with temperature to 28°F (−2°C) resulting in freezing of
tissue, intracellular ice crystal formation, a/o microvascular
thrombosis
2. Immediate tx: includes removing all damp, cold clothing,
immersion in warm (104°F, 40°C) saline (usu 20–30 min), and prn
analgesia. Aggressively tx hypothermia as well
3. A conservative approach to wound débridement is appropriate as
the level of necrosis may not be immediately apparent. Unless wet
gangrene develops, there is no urgency for débridement or ampu-
tation. Early use of angiographic-guided thrombolytics may help
preserve tissue
A. MALIGNANCY
1. Basal cell carcinoma (BCCA)
a. Most common, and usually most indolent, skin cancer; rarely metas-
tasize, 2–5-mm margins usu adequate
i. Waxy, often ulcerated lesion with rolled borders is classic;
originally termed “rodent ulcer”
b. Risk factors: UV exposure, psoralens, arsenic, fair complexion,
immunosuppression, nevus sebaceous of Jadassohn: irregular flesh-
colored nodular/popular lesion usu of head/neck, usu arising in child-
hood, with ~15% risk of malignant transformation to BCCA; 95%
between 40 and 79 years old
c. Types
i. Morpheaform: most aggressive, Mohs surgery
ii. Nodular: most common (70%)
iii. Superficial spreading: usu scaly red lesion on trunk
d. Associated syndromes/conditions
i. Gorlin (basal cell nevus) syndrome: multiple BCCAs, odonto-
genic keratocysts, palmoplantar pitting, etc.
ii. Albinism
iii. Xeroderma pigmentosum
e. Treatment
i. Surgery
– WLE: no standard recommendation for margins, but large/
aggressive variants may warrant up to 1 cm
– Mohs: for recurrent or dz in high value areas (e.g., near
medial canthus), morpheaform
ii. Other (usu reserved for lesions <2 cm or those unfit for surgery)
– 5-FU, imiquimod, XRT, electrodessication and curettage,
laser, cryosurgery
B. VASCULAR ANOMALIES
1. Infantile hemangiomas
a. Epidemiology/etiology
i. Most common tumors of infancy (up to 12% by 1 year of age in
white children)
ii. Possibly result from embolized placental cells or clonal expan-
sion of endothelial cell via germline mutation
*Note: Distinguish from the rarer congenital hemangioma, which is fully devel-
oped at birth and may be classified as either rapidly involuting congenital
hemangioma (RICH) or non-involuting congenital hemangioma (NICH).
Mulliken JB et al., “Vascular anomalies: classification, diagnosis, and
natural history,” Facial Plast Surg Clin North Am. 2001 Nov;9(4):495–504
iii. Tx is observation, not steroids
b. Pathology/presentation
i. Typically appear in first 2 weeks after birth, although deep or
visceral ones may take several months
ii. 80% solitary, most common on head, neck (60%), followed by
trunk (25%) and extremities (15%)
iii. >5 cutaneous hemangiomas → increased risk of visceral hem-
angioma; obtain abdominal CT scan
iv. Most spontaneously resolve (50% by 5 y, 70% by 7 y, 90% by 9 y,
little change after 10 y however). More rapid involution (improved
by fourth year) results in more favorable long-term appearance
v. Once resolved, do not recur
vi. Phases
– Proliferating: typically no longer than 20 months
– Involuting: 6 mo–5 yo
– Involuted: usu after 5 yo
vii. Complications that may prompt intervention
– Bleeding, ulceration (10%)
– Airway compromise (subglottic hemangiomas)
– Visual obstruction (periorbital: note amblyopia and other
visual changes—strabismus, optic atrophy can develop in
only 1 week in infants)
– Kasabach-Merritt syndrome (thrombocytopenia from local
intravascular coagulopathy)
• Only seen with kaposiform hemangioendotheliomas and
tufted angiomas
– Congestive heart failure (CHF)
• Only seen with diffuse neonatal hemangiomatosis or
large visceral (esp hepatic) hemangiomas
c. Dx
i. Physical exam: Most often in head/neck region. Usually not
present at birth, but invariably by 6 months of age. Color (red,
blue, purple) varies with depth.
ii. Radiographic
– U/S: homogenous, high degree of shunting
– CT: well-circumscribed, homogeneous masses
– MRI: T1 intermediate intensity; Tw moderate hyperintensity,
enhances w/gadolinium
d. Tx
i. Majority require none. Up to 65% involute by 5 yo, and 70% by 7 yo,
and 90% by 9 yo, and tx is reserved for complications such as bleeding,
infections, visual impairment, ulceration, skeletal distortion, nasopha-
ryngeal or external ear obstruction, Kasabach-Merritt, and CHF
ii. Nonsurgical
– Steroids (side effects include growth retardation if prolonged
use)
• PO (usual): prednisone 2–3 mg/kg × 2–3 weeks, then taper
• Intralesional: triamcinolone (40–80 mg) or betametha-
sone (6–12 mg) under general anesthesia
○ Complications include skin necrosis and blindness
from embolization (most avoid injecting eyelid lesions)
• IV (reserved for Kasabach-Merritt)
– IFN-alpha (side effects include flu-like syndrome, neutrope-
nia, abnormal LFTs, and spastic diplegia)
• Reserved for failure of steroids, particularly in life- or
vision-threatening cases
• SC injection 1–2 M u/m2 /day; tx may last several years,
with some degree of regression in >80%, but complete
resolution in <50%
– Laser (limited by depth)
• Pulseddye lasers most common, but CO2, Nd-YAG, others
used with some effect
iii. Surgery: usu reserved for managing urgent situations
refractory to medical tx (e.g., eyelid lesion causing amblyopia)
or excision of residual appendages after involution
C. VASCULAR MALFORMATIONS
1. Classifi cation
a. Slow-flow
i. Capillary
– Formerly called port wine stains
• When in trigeminal distribution, may be part of Sturge-
Weber syndrome
○ Associated with glaucoma, seizures, leptomeningeal/
choroid plexus calcification
○ Warrants referral to neurologist, brain MRI; if in V1,
ophthalmology
– Skin lesion usu managed with pulsed dye laser (585 nm)
ii. Lymphatic
– Classification
• Macrocystic (formerly cystic hygroma)
• Microcystic (formerly lymphangioma)
– Associated with soft-tissue and/or bony hypertrophy
– Size often increases with inflammation/infection, or hemor-
rhage into lesion
– Tx
• Aggressively address infections or sources of inflamma-
tion to minimize sx
A Allopurinol
Abbé flap, lips, 41 for Dupuytren’s disease, 109
Abdominal wall reconstruction, flap survival and, 15
137–138 for gout, 111
Abdominoplasty, aesthetics, 139 ALND. See Axillary lymph node
Abducens nerve (CNVI), 24t dissection
Abductor digit minimi, 88t Alveolar bone grafting, 70
Abductor pollicis brevis, 89t Alveolar cleft, 66
Abductor pollicis longus, 89t Alveolar process, 22
Accommodation, pupils, 30 Alveolar ridge, 32
Acetylcysteine, inhalation Ameloblastoma, 60
injury, 149 Amides, 19
Achondroplasia, 128 Amputation, leg trauma, 141
Acids, chemical burns, 151 Amrinone, flap survival and, 15
Actinic cell carcinoma, parotid Anastomoses
gland, 58 end-to-end, 13
Advancement flap, 5 end-to-side, 13
AER. See Apical ectodermal ridge Anatomic snuff box, 84
Aesthetics, 79–82 Anesthesia
abdominoplasty, 139 local, 19
blepharoplasty, 81–82 regional, 17–19
brow lift, 82 Angle fracture, mandibular,
evaluate, 79 treatment, 53–54
injectable fillers and Botox, 164 Angulation fracture, 98
liposuction, 139 Ankle, reconstruction, 143
massive weight loss Anterior interosseous
patients, 139 syndrome, 116
rhinoplasty, 79–80 Anterolateral thigh (ALT) flap, 38
rhytidectomy, 80 Antia-Buch technique, ear, 43
Afferent papillary defect, 30 Anticoagulants, flap survival
Airway and breathing, and, 15
burns, 145 Antimicrobial agents, topical, for
Alar batten graft, nose, 39 burn patients, 148t–149t
Albinism, 157 Apert syndrome, 73, 127
Aleve, inflammation and, 2 Apical ectodermal ridge, 121
Alloplastic implants, orbital Areolar reconstruction, 132
fractures, 48 Areolar tattoo, 132
Alloplastic reconstruction, Argon dye laser, 163t
TMJ, 41 Argon laser, 163t
Alloplasts, mandible, 40 Arnold’s nerve, 31